Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS2W
Performance in the last:
Follow this Portfolio
1D 1.2 %
1W 0.6 %
2W 0.6 %
1M 1.6 %
3M 14.5 %
6M -67.3 %
9M -64.3 %
1Y -67.2 %
Alpha
-80.0%
Beta
0.47
sharpe-R
-0.85
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:47
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -75.48%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
PDSB PDS Biotechnology Corporation Equity Buy 10.1% 3.65%
NVAX Novavax, Inc. Equity Buy 9.92% 1.81%
ESPR Esperion Therapeutics, Inc. Equity Buy 13.26% 2.3%
RGNX REGENXBIO Inc. Equity Buy 12.14% 1.89%
AGEN Agenus Inc. Equity Buy 12.05% 5.06%
LLY Eli Lilly and Company Equity Buy 11.11% -3.08%
SRNE Sorrento Therapeutics, Inc. Equity Buy 12.14% -8.33%
IRTC iRhythm Technologies, Inc. Equity Buy 12.53% -6.66%
TDOC Teladoc Health, Inc. Equity Buy 15.12% 12.61%
MRSN Mersana Therapeutics, Inc. Equity Buy 12.98% -3.32%
CARA Cara Therapeutics, Inc. Equity Sell -5.67% 4.98%
SIGA SIGA Technologies, Inc. Equity Sell -6.16% -4.93%
BGNE BeiGene, Ltd. Equity Sell -5.93% -0.63%
CHRS Coherus BioSciences, Inc. Equity Sell -5.66% 0.95%
KIDS OrthoPediatrics Corp. Equity Sell -6.59% 0%
The percentage of cash held in the portfolio is: 8.65%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.1% 3.65%
NVAX Novavax, Inc. Buy 9.92% 1.81%
ESPR Esperion Therapeutics, Inc. Buy 13.26% 2.3%
RGNX REGENXBIO Inc. Buy 12.14% 1.89%
AGEN Agenus Inc. Buy 12.05% 5.06%
LLY Eli Lilly and Company Buy 11.11% -3.08%
SRNE Sorrento Therapeutics, Inc. Buy 12.14% -8.33%
IRTC iRhythm Technologies, Inc. Buy 12.53% -6.66%
TDOC Teladoc Health, Inc. Buy 15.12% 12.61%
MRSN Mersana Therapeutics, Inc. Buy 12.98% -3.32%
CARA Cara Therapeutics, Inc. Sell -5.67% 4.98%
SIGA SIGA Technologies, Inc. Sell -6.16% -4.93%
BGNE BeiGene, Ltd. Sell -5.93% -0.63%
CHRS Coherus BioSciences, Inc. Sell -5.66% 0.95%
KIDS OrthoPediatrics Corp. Sell -6.59% 0%
The percentage of cash held in the portfolio is: 8.65%
New Assets Added
  • KIDS
Assets Removed
None
Assets Rebalanced
Asset Action Weight
ESPR Buy 1.41%
RGNX Buy 1.46%
SRNE Buy 1.63%
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.16% 1.66%
NVAX Novavax, Inc. Buy 10.38% 3.94%
RGNX REGENXBIO Inc. Buy 10.78% 0.24%
ESPR Esperion Therapeutics, Inc. Buy 10.88% 1.15%
SRNE Sorrento Therapeutics, Inc. Buy 10.39% -11.67%
AGEN Agenus Inc. Buy 12.06% 2.53%
LLY Eli Lilly and Company Buy 11.62% -1.23%
IRTC iRhythm Technologies, Inc. Buy 13.25% -3.8%
TDOC Teladoc Health, Inc. Buy 13.89% 0.87%
MRSN Mersana Therapeutics, Inc. Buy 12.86% -6.64%
CARA Cara Therapeutics, Inc. Sell -5.83% 4.63%
SIGA SIGA Technologies, Inc. Sell -6.41% -6.39%
BGNE BeiGene, Ltd. Sell -6.04% -0.09%
CHRS Coherus BioSciences, Inc. Sell -5.86% 0%
The percentage of cash held in the portfolio is: 7.88%
New Assets Added
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.82% -0.33%
NVAX Novavax, Inc. Buy 10.56% 7.17%
RGNX REGENXBIO Inc. Buy 10.72% 1.02%
ESPR Esperion Therapeutics, Inc. Buy 11.65% 9.77%
SRNE Sorrento Therapeutics, Inc. Buy 8.7% -25%
AGEN Agenus Inc. Buy 12.25% 5.56%
LLY Eli Lilly and Company Buy 11.46% -1.21%
IRTC iRhythm Technologies, Inc. Buy 13.59% 0%
TDOC Teladoc Health, Inc. Buy 13.59% 0%
MRSN Mersana Therapeutics, Inc. Buy 13.59% 0%
CARA Cara Therapeutics, Inc. Sell -5.65% 6.41%
SIGA SIGA Technologies, Inc. Sell -6.25% -5.19%
BGNE BeiGene, Ltd. Sell -6.03% -1.13%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IRTC
  • TDOC
  • MRSN
Assets Removed
None
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.02% 1.33%
NVAX Novavax, Inc. Buy 9.28% -6.14%
RGNX REGENXBIO Inc. Buy 10.2% -4.17%
ESPR Esperion Therapeutics, Inc. Buy 10.71% 0.57%
SRNE Sorrento Therapeutics, Inc. Buy 11.64% 0%
AGEN Agenus Inc. Buy 11.64% 0%
LLY Eli Lilly and Company Buy 11.64% 0%
CARA Cara Therapeutics, Inc. Sell -5.82% 3.91%
SIGA SIGA Technologies, Inc. Sell -6.25% -4.79%
BGNE BeiGene, Ltd. Sell -5.98% 0%
The percentage of cash held in the portfolio is: 42.9%
New Assets Added
  • SRNE
  • AGEN
  • LLY
  • BGNE
Assets Removed
None
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.12% 2.99%
NVAX Novavax, Inc. Buy 9.51% -3.23%
RGNX REGENXBIO Inc. Buy 10.58% 0%
ESPR Esperion Therapeutics, Inc. Buy 10.58% 0%
CARA Cara Therapeutics, Inc. Sell -6.3% -4.63%
SIGA SIGA Technologies, Inc. Sell -5.93% 0%
The percentage of cash held in the portfolio is: 71.42%
New Assets Added
  • RGNX
  • ESPR
  • SIGA
Assets Removed
None
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.8% 0%
NVAX Novavax, Inc. Buy 9.8% 0%
CARA Cara Therapeutics, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 86.4%
New Assets Added
  • PDSB
  • NVAX
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
KIDS Sell All 12.95%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
KIDS OrthoPediatrics Corp. Buy 12.4% 15.23%
The percentage of cash held in the portfolio is: 87.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
OFIX Buy All -7.98%
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
KIDS OrthoPediatrics Corp. Buy 11.76% 8.86%
OFIX Orthofix Medical Inc. Sell -6.14% -3.87%
The percentage of cash held in the portfolio is: 94.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
ICUI Sell All 4.94%
VCYT Sell All 3.64%
INGN Sell All 4.71%
CPRX Sell All 13.33%
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ICUI ICU Medical, Inc. Buy 11.08% 3.93%
VCYT Veracyte, Inc. Buy 10.49% 5.54%
INGN Inogen, Inc. Buy 10.21% 6.86%
CPRX Catalyst Pharmaceuticals, Inc. Buy 11.37% 11.86%
KIDS OrthoPediatrics Corp. Buy 12.21% 13.75%
OFIX Orthofix Medical Inc. Sell -6.08% -3.62%
The percentage of cash held in the portfolio is: 50.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
MD Sell All 12.88%
EXEL Sell All -0.72%
Assets Rebalanced
None
2024-08-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
MD Pediatrix Medical Group, Inc. Buy 11.9% 11.63%
EXEL Exelixis, Inc. Buy 11.17% -0.15%
ICUI ICU Medical, Inc. Buy 11.05% 2.58%
VCYT Veracyte, Inc. Buy 10.62% 5.74%
INGN Inogen, Inc. Buy 10.39% 7.54%
CPRX Catalyst Pharmaceuticals, Inc. Buy 11.61% 13.06%
KIDS OrthoPediatrics Corp. Buy 11.18% 3.08%
OFIX Orthofix Medical Inc. Sell -6.05% -2%
The percentage of cash held in the portfolio is: 28.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
THC Sell All 6.2%
GKOS Sell All 6.82%
AXSM Sell All 3.09%
Assets Rebalanced
None
2024-08-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 11.16% 6.86%
GKOS Glaukos Corporation Buy 11.16% 8.37%
AXSM Axsome Therapeutics, Inc. Buy 11.16% 5.57%
MD Pediatrix Medical Group, Inc. Buy 11.86% 11.94%
EXEL Exelixis, Inc. Buy 11.16% 0.26%
ICUI ICU Medical, Inc. Buy 11.03% 2.98%
VCYT Veracyte, Inc. Buy 10.78% 7.91%
INGN Inogen, Inc. Buy 10.45% 8.83%
CPRX Catalyst Pharmaceuticals, Inc. Buy 11.16% 9.23%
KIDS OrthoPediatrics Corp. Buy 11.16% 3.44%
OFIX Orthofix Medical Inc. Sell -6.04% -2.43%
The percentage of cash held in the portfolio is: -5.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
CVS Buy All -1.71%
Assets Rebalanced
Asset Action Weight
INGN Sell -1.54%
EXEL Sell -1.16%
THC Sell -1.29%
KIDS Sell -1.32%
GKOS Sell -1.41%
CPRX Sell -2.25%
AXSM Sell -2.49%
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.6% 7.18%
GKOS Glaukos Corporation Buy 12.78% 9.17%
AXSM Axsome Therapeutics, Inc. Buy 13.15% 0.76%
EXEL Exelixis, Inc. Buy 12.32% -0.64%
MD Pediatrix Medical Group, Inc. Buy 11.57% 8.1%
CPRX Catalyst Pharmaceuticals, Inc. Buy 13.46% 8.58%
INGN Inogen, Inc. Buy 12.26% 10.11%
ICUI ICU Medical, Inc. Buy 11.32% 4.68%
VCYT Veracyte, Inc. Buy 11.05% 9.61%
KIDS OrthoPediatrics Corp. Buy 12.05% -1.01%
CVS CVS Health Corporation Sell -7.53% -0.93%
OFIX Orthofix Medical Inc. Sell -6% -0.62%
The percentage of cash held in the portfolio is: -9.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.93%
CDXS Buy All 11.82%
Assets Rebalanced
Asset Action Weight
ICUI Sell -1.65%
VCYT Sell -2.53%
INGN Sell -1.39%
AXSM Buy 1.69%
2024-08-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.55% 6.15%
GKOS Glaukos Corporation Buy 12.62% 7.22%
AXSM Axsome Therapeutics, Inc. Buy 11.45% 0.11%
EXEL Exelixis, Inc. Buy 12.37% -0.79%
MD Pediatrix Medical Group, Inc. Buy 11.51% 6.96%
VCYT Veracyte, Inc. Buy 13.58% 8.98%
INGN Inogen, Inc. Buy 13.47% 8.05%
CPRX Catalyst Pharmaceuticals, Inc. Buy 13.56% 8.8%
ICUI ICU Medical, Inc. Buy 13.02% 4.47%
KIDS OrthoPediatrics Corp. Buy 12.24% 0%
VREX Varex Imaging Corporation Sell -5.81% 3.08%
CDXS Codexis, Inc. Sell -5.1% 14.85%
CVS CVS Health Corporation Sell -7.47% 0.43%
OFIX Orthofix Medical Inc. Sell -6.1% -1.75%
The percentage of cash held in the portfolio is: -1.9%
New Assets Added
  • KIDS
Assets Removed
Asset Action Perf %
RCM Sell All -1.13%
BLUE Buy All 34.26%
Assets Rebalanced
None
2024-08-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 12.86% -1.27%
THC Tenet Healthcare Corporation Buy 12.8% 3.64%
GKOS Glaukos Corporation Buy 12.8% 4.07%
AXSM Axsome Therapeutics, Inc. Buy 11.87% -0.7%
EXEL Exelixis, Inc. Buy 13.23% 1.55%
MD Pediatrix Medical Group, Inc. Buy 11.82% 5.19%
VCYT Veracyte, Inc. Buy 13% -0.17%
INGN Inogen, Inc. Buy 13.15% 1.03%
CPRX Catalyst Pharmaceuticals, Inc. Buy 13.73% 5.46%
ICUI ICU Medical, Inc. Buy 12.74% -2.17%
BLUE bluebird bio, Inc. Sell -5.63% 9.26%
VREX Varex Imaging Corporation Sell -5.2% 16.95%
CDXS Codexis, Inc. Sell -5.35% 14.55%
CVS CVS Health Corporation Sell -7.57% 3.46%
OFIX Orthofix Medical Inc. Sell -6.26% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OFIX
Assets Removed
Asset Action Perf %
RVNC Buy All -95.85%
Assets Rebalanced
Asset Action Weight
MD Sell -1.88%
AXSM Sell -2.45%
THC Sell -2.14%
GKOS Sell -2.2%
RCM Buy 2.86%
2024-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.6% -1.13%
GKOS Glaukos Corporation Buy 14.26% 3.2%
THC Tenet Healthcare Corporation Buy 14.19% 2.7%
AXSM Axsome Therapeutics, Inc. Buy 13.74% -0.61%
MD Pediatrix Medical Group, Inc. Buy 12.75% 2.08%
EXEL Exelixis, Inc. Buy 12.79% 2.45%
ICUI ICU Medical, Inc. Buy 12.49% 0%
INGN Inogen, Inc. Buy 12.49% 0%
VCYT Veracyte, Inc. Buy 12.49% 0%
CPRX Catalyst Pharmaceuticals, Inc. Buy 12.49% 0%
RVNC Revance Therapeutics, Inc. Sell -5.21% 12.46%
BLUE bluebird bio, Inc. Sell -5.56% 6.48%
VREX Varex Imaging Corporation Sell -5.27% 12.25%
CDXS Codexis, Inc. Sell -5.73% 4.55%
CVS CVS Health Corporation Sell -7.52% -0.07%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ICUI
  • INGN
  • VCYT
  • CPRX
Assets Removed
None
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.67% -1.2%
GKOS Glaukos Corporation Buy 13.83% -0.69%
THC Tenet Healthcare Corporation Buy 13.86% -0.46%
AXSM Axsome Therapeutics, Inc. Buy 13.65% -1.95%
MD Pediatrix Medical Group, Inc. Buy 12.58% 0%
EXEL Exelixis, Inc. Buy 12.58% 0%
RVNC Revance Therapeutics, Inc. Sell -5.01% 16.32%
BLUE bluebird bio, Inc. Sell -5.21% 12.96%
VREX Varex Imaging Corporation Sell -5.33% 11.79%
CDXS Codexis, Inc. Sell -5.53% 8.48%
CVS CVS Health Corporation Sell -7.4% 2.32%
The percentage of cash held in the portfolio is: 52.32%
New Assets Added
  • MD
  • EXEL
Assets Removed
Asset Action Perf %
TNDM Sell All -11.11%
CERS Sell All -11.06%
Assets Rebalanced
None
2024-08-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.57% -1.27%
TNDM Tandem Diabetes Care, Inc. Buy 11.46% 4.13%
CERS Cerus Corporation Buy 10.26% -6.81%
GKOS Glaukos Corporation Buy 13.79% 0%
THC Tenet Healthcare Corporation Buy 13.79% 0%
AXSM Axsome Therapeutics, Inc. Buy 13.79% 0%
RVNC Revance Therapeutics, Inc. Sell -5.42% 8.61%
BLUE bluebird bio, Inc. Sell -5.6% 5.56%
VREX Varex Imaging Corporation Sell -5.37% 10.25%
CDXS Codexis, Inc. Sell -5.84% 2.42%
CVS CVS Health Corporation Sell -7.57% -0.92%
The percentage of cash held in the portfolio is: 57.15%
New Assets Added
  • GKOS
  • THC
  • AXSM
Assets Removed
None
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.62% -1.27%
TNDM Tandem Diabetes Care, Inc. Buy 10.84% -2.11%
CERS Cerus Corporation Buy 10.46% -5.53%
RVNC Revance Therapeutics, Inc. Sell -5.42% 9.2%
BLUE bluebird bio, Inc. Sell -5.47% 8.33%
VREX Varex Imaging Corporation Sell -5.71% 5.08%
CDXS Codexis, Inc. Sell -5.86% 2.73%
CVS CVS Health Corporation Sell -7.54% 0%
The percentage of cash held in the portfolio is: 99.08%
New Assets Added
  • CVS
Assets Removed
None
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.74% -0.57%
TNDM Tandem Diabetes Care, Inc. Buy 11.12% 0%
CERS Cerus Corporation Buy 11.12% 0%
RVNC Revance Therapeutics, Inc. Sell -5.69% 5.04%
BLUE bluebird bio, Inc. Sell -6.16% -2.78%
VREX Varex Imaging Corporation Sell -6.05% 0%
CDXS Codexis, Inc. Sell -6.05% 0%
The percentage of cash held in the portfolio is: 91.97%
New Assets Added
  • TNDM
  • CERS
  • VREX
  • CDXS
Assets Removed
None
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.8% 0%
RVNC Revance Therapeutics, Inc. Sell -6% 0%
BLUE bluebird bio, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 102.2%
New Assets Added
  • RCM
  • RVNC
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
SNDX Sell All 3.15%
SAGE Sell All 14.04%
ATXS Sell All 14.43%
TVTX Sell All 3.06%
BLUE Sell All 24%
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
SNDX Syndax Pharmaceuticals, Inc. Buy 10.84% 3.63%
SAGE Sage Therapeutics, Inc. Buy 11.67% 11.6%
ATXS Astria Therapeutics, Inc. Buy 10.96% 15.51%
TVTX Travere Therapeutics, Inc. Buy 9% 1.69%
BLUE bluebird bio, Inc. Buy 9.86% 14%
The percentage of cash held in the portfolio is: 47.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
CERS Sell All 18.37%
AVXL Sell All 31.04%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Buy 10.15% 12.24%
AVXL Anavex Life Sciences Corp. Buy 10.08% 21.51%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.03% 2.26%
SAGE Sage Therapeutics, Inc. Buy 11.56% 7.15%
ATXS Astria Therapeutics, Inc. Buy 10.76% 9.91%
TVTX Travere Therapeutics, Inc. Buy 9.43% 3.27%
BLUE bluebird bio, Inc. Buy 9.37% 5%
The percentage of cash held in the portfolio is: 27.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
MCRB Sell All 25.9%
MODV Buy All 7.31%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Buy 10.05% 12.76%
AVXL Anavex Life Sciences Corp. Buy 10.35% 26.61%
MCRB Seres Therapeutics, Inc. Buy 9.14% 29.5%
SNDX Syndax Pharmaceuticals, Inc. Buy 10.95% 2.88%
SAGE Sage Therapeutics, Inc. Buy 11.29% 6.1%
ATXS Astria Therapeutics, Inc. Buy 10.47% 8.44%
TVTX Travere Therapeutics, Inc. Buy 9.31% 3.37%
BLUE bluebird bio, Inc. Buy 10.12% 15%
MODV ModivCare Inc. Sell -4.5% 6.4%
The percentage of cash held in the portfolio is: 22.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
NKTR Sell All 4.65%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 10.26% 12.4%
CERS Cerus Corporation Buy 10.26% 20.41%
AVXL Anavex Life Sciences Corp. Buy 10.26% 31.26%
MCRB Seres Therapeutics, Inc. Buy 10.26% 52.11%
SNDX Syndax Pharmaceuticals, Inc. Buy 10.67% 4.96%
SAGE Sage Therapeutics, Inc. Buy 10.77% 5.93%
ATXS Astria Therapeutics, Inc. Buy 10.26% 11.19%
TVTX Travere Therapeutics, Inc. Buy 9.34% 8.43%
BLUE bluebird bio, Inc. Buy 10.26% 22%
MODV ModivCare Inc. Sell -4.6% -0.04%
The percentage of cash held in the portfolio is: 12.26%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
TVTX Sell -1.69%
ATXS Sell -1.05%
NKTR Sell -1.7%
BLUE Sell -2.15%
CERS Sell -3.11%
AVXL Sell -4.31%
MCRB Sell -6.62%
2024-07-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 12.14% 13.95%
AVXL Anavex Life Sciences Corp. Buy 14.37% 29.27%
CERS Cerus Corporation Buy 13.55% 21.94%
MCRB Seres Therapeutics, Inc. Buy 14.51% 30.52%
TVTX Travere Therapeutics, Inc. Buy 10.96% 7.69%
ATXS Astria Therapeutics, Inc. Buy 11.83% 16.19%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.19% 9.92%
SAGE Sage Therapeutics, Inc. Buy 10.79% 6.02%
BLUE bluebird bio, Inc. Buy 13.74% 35%
MODV ModivCare Inc. Sell -4.7% -2.16%
The percentage of cash held in the portfolio is: -8.37%
New Assets Added
None
Assets Removed
Asset Action Perf %
DNLI Buy All -10.12%
AGEN Buy All -21.82%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 11.85% 8.53%
AVXL Anavex Life Sciences Corp. Buy 14.73% 29.27%
CERS Cerus Corporation Buy 13.08% 14.8%
MCRB Seres Therapeutics, Inc. Buy 13.93% 22.3%
TVTX Travere Therapeutics, Inc. Buy 10.79% 3.37%
ATXS Astria Therapeutics, Inc. Buy 12.12% 16.09%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.27% 8.02%
SAGE Sage Therapeutics, Inc. Buy 10.74% 2.88%
BLUE bluebird bio, Inc. Buy 13.78% 32%
DNLI Denali Therapeutics Inc. Sell -5.77% -7.31%
AGEN Agenus Inc. Sell -5.52% -7.36%
MODV ModivCare Inc. Sell -4.58% 2.87%
The percentage of cash held in the portfolio is: 3.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Buy All -37.1%
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 12.4% 5.43%
AVXL Anavex Life Sciences Corp. Buy 13.45% 9.53%
CERS Cerus Corporation Buy 13.22% 7.65%
MCRB Seres Therapeutics, Inc. Buy 12.34% 0.51%
TVTX Travere Therapeutics, Inc. Buy 11.6% 3.16%
ATXS Astria Therapeutics, Inc. Buy 12.41% 10.4%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.71% 4.12%
SAGE Sage Therapeutics, Inc. Buy 11.51% 2.31%
BLUE bluebird bio, Inc. Buy 12.71% 13%
DNLI Denali Therapeutics Inc. Sell -6.15% -6.21%
AGEN Agenus Inc. Sell -5.87% -5.92%
MODV ModivCare Inc. Sell -5.07% 0.28%
NUTX Nutex Health Inc. Sell -7.57% -9.91%
The percentage of cash held in the portfolio is: 13.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Buy All -16.25%
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 11.65% -4.65%
AVXL Anavex Life Sciences Corp. Buy 12.84% 0.67%
CERS Cerus Corporation Buy 12.88% 1.02%
MCRB Seres Therapeutics, Inc. Buy 13.37% 4.83%
TVTX Travere Therapeutics, Inc. Buy 11.68% 0%
ATXS Astria Therapeutics, Inc. Buy 11.68% 0%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.68% 0%
SAGE Sage Therapeutics, Inc. Buy 11.68% 0%
BLUE bluebird bio, Inc. Buy 11.68% 0%
DNLI Denali Therapeutics Inc. Sell -5.8% 3.59%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.02% 0%
AGEN Agenus Inc. Sell -6.17% -7.23%
MODV ModivCare Inc. Sell -4.85% 8.17%
NUTX Nutex Health Inc. Sell -7.15% 0%
The percentage of cash held in the portfolio is: 20.84%
New Assets Added
  • TVTX
  • ATXS
  • SNDX
  • SAGE
  • BLUE
  • NUTX
Assets Removed
None
Assets Rebalanced
None
2024-07-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 11.89% -3.88%
AVXL Anavex Life Sciences Corp. Buy 12.9% 0%
CERS Cerus Corporation Buy 12.9% 0%
MCRB Seres Therapeutics, Inc. Buy 12.9% 0%
DNLI Denali Therapeutics Inc. Sell -5.93% 2.53%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.09% 0%
AGEN Agenus Inc. Sell -6.24% -7.09%
MODV ModivCare Inc. Sell -5.27% 1.49%
The percentage of cash held in the portfolio is: 72.93%
New Assets Added
  • AVXL
  • CERS
  • MCRB
Assets Removed
Asset Action Perf %
INGN Buy All -14.99%
Assets Rebalanced
None
2024-07-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 12.27% 0%
INGN Inogen, Inc. Sell -6.5% -7.56%
DNLI Denali Therapeutics Inc. Sell -5.87% 2.76%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.3% -4.37%
AGEN Agenus Inc. Sell -6.02% -4.13%
MODV ModivCare Inc. Sell -5.3% 0%
The percentage of cash held in the portfolio is: 117.73%
New Assets Added
  • NKTR
  • MODV
Assets Removed
None
Assets Rebalanced
None
2024-07-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Sell -6.34% -5.35%
DNLI Denali Therapeutics Inc. Sell -5.9% 2.02%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.24% -3.75%
AGEN Agenus Inc. Sell -5.76% 0%
The percentage of cash held in the portfolio is: 124.24%
New Assets Added
None
Assets Removed
Asset Action Perf %
SUPN Sell All NA
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
SUPN Supernus Pharmaceuticals, Inc. Buy 12.44% -2.95%
INGN Inogen, Inc. Sell -6.34% -5.35%
DNLI Denali Therapeutics Inc. Sell -5.9% 2.02%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.24% -3.75%
AGEN Agenus Inc. Sell -5.76% 0%
The percentage of cash held in the portfolio is: 111.8%
New Assets Added
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
SUPN Supernus Pharmaceuticals, Inc. Buy 12.29% -3.84%
INGN Inogen, Inc. Sell -6% 0%
DNLI Denali Therapeutics Inc. Sell -6% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 105.71%
New Assets Added
  • INGN
  • DNLI
  • LXRX
Assets Removed
Asset Action Perf %
IBRX Sell All -0.8%
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
IBRX ImmunityBio, Inc. Buy 13.31% 4.98%
SUPN Supernus Pharmaceuticals, Inc. Buy 12.65% 0.26%
The percentage of cash held in the portfolio is: 74.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
MASI Sell All -1.76%
TDOC Buy All -1.91%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
MASI Masimo Corporation Buy 14.73% -1.06%
IBRX ImmunityBio, Inc. Buy 14.56% 16.69%
SUPN Supernus Pharmaceuticals, Inc. Buy 12.28% -1.08%
TDOC Teladoc Health, Inc. Sell -6.03% 2.01%
The percentage of cash held in the portfolio is: 64.46%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACRS Sell All 15.18%
ATRC Sell All -10.48%
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 16.99% 15.18%
MASI Masimo Corporation Buy 14.33% -3.83%
IBRX ImmunityBio, Inc. Buy 14.71% 17.82%
ATRC AtriCure, Inc. Buy 11.51% -7.32%
SUPN Supernus Pharmaceuticals, Inc. Buy 12.47% 0.41%
TDOC Teladoc Health, Inc. Sell -6.41% -4.12%
The percentage of cash held in the portfolio is: 36.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDGL Sell All 11.42%
ALT Buy All -14.06%
PEN Buy All 7.26%
Assets Rebalanced
None
2024-06-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.29% 9.24%
ACRS Aclaris Therapeutics, Inc. Buy 15.53% 2.68%
MASI Masimo Corporation Buy 14.97% -2%
IBRX ImmunityBio, Inc. Buy 14.91% 16.53%
ATRC AtriCure, Inc. Buy 12.29% -3.49%
SUPN Supernus Pharmaceuticals, Inc. Buy 12.85% 0.9%
ALT Altimmune, Inc. Sell 12.54% -2.4%
PEN Penumbra, Inc. Sell -5.56% 5.05%
TDOC Teladoc Health, Inc. Sell -6.16% 2.41%
The percentage of cash held in the portfolio is: 21.34%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
MCRB Buy All -26.38%
ABUS Buy All 4.69%
Assets Rebalanced
None
2024-06-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.07% 5.07%
ACRS Aclaris Therapeutics, Inc. Buy 15.39% 0.89%
MASI Masimo Corporation Buy 15.01% -2.58%
IBRX ImmunityBio, Inc. Buy 13.46% 4.33%
ATRC AtriCure, Inc. Buy 12.84% 0%
SUPN Supernus Pharmaceuticals, Inc. Buy 12.84% 0%
MCRB Seres Therapeutics, Inc. Sell -7.94% -22.48%
ABUS Arbutus Biopharma Corporation Sell -5.98% 7.81%
PEN Penumbra, Inc. Sell -5.51% 6.71%
ALT Altimmune, Inc. Sell -5.61% 5.11%
TDOC Teladoc Health, Inc. Sell -6.18% 3.02%
The percentage of cash held in the portfolio is: 54.59%
New Assets Added
  • ATRC
  • SUPN
Assets Removed
Asset Action Perf %
SGRY Sell All -11.04%
PDSB Sell All -15%
Assets Rebalanced
None
2024-06-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.14% 8.29%
ACRS Aclaris Therapeutics, Inc. Buy 15.08% 0.89%
SGRY Surgery Partners, Inc. Buy 13.44% -5.93%
MASI Masimo Corporation Buy 15.32% 1.46%
PDSB PDS Biotechnology Corporation Buy 13.79% -8.67%
IBRX ImmunityBio, Inc. Buy 12.65% 0%
MCRB Seres Therapeutics, Inc. Sell -7.34% -15.64%
ABUS Arbutus Biopharma Corporation Sell -5.97% 5.94%
PEN Penumbra, Inc. Sell -5.42% 6.4%
ALT Altimmune, Inc. Sell -5.47% 5.59%
TDOC Teladoc Health, Inc. Sell -6.33% -1.41%
The percentage of cash held in the portfolio is: 53.12%
New Assets Added
  • IBRX
Assets Removed
Asset Action Perf %
ARWR Sell All -8.52%
Assets Rebalanced
None
2024-06-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.13% 8.57%
ACRS Aclaris Therapeutics, Inc. Buy 15.01% 0.89%
SGRY Surgery Partners, Inc. Buy 13.43% -5.63%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.86% -2.6%
MASI Masimo Corporation Buy 15.2% 1.11%
PDSB PDS Biotechnology Corporation Buy 13.38% -11%
MCRB Seres Therapeutics, Inc. Sell -6.91% -9.28%
ABUS Arbutus Biopharma Corporation Sell -6.05% 4.38%
PEN Penumbra, Inc. Sell -5.74% 0.39%
ALT Altimmune, Inc. Sell -5.45% 5.43%
TDOC Teladoc Health, Inc. Sell -6.31% -1.61%
The percentage of cash held in the portfolio is: 52.46%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGIO Sell All -10.05%
Assets Rebalanced
None
2024-06-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGIO Agios Pharmaceuticals, Inc. Buy 10.6% -6.84%
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.06% 8.91%
ACRS Aclaris Therapeutics, Inc. Buy 15.47% 5.36%
SGRY Surgery Partners, Inc. Buy 13.18% -6.12%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 14.08% 0.27%
MASI Masimo Corporation Buy 15.03% 1.37%
PDSB PDS Biotechnology Corporation Buy 13.77% -7.17%
MCRB Seres Therapeutics, Inc. Sell -7.19% -15.31%
ABUS Arbutus Biopharma Corporation Sell -6.12% 1.87%
PEN Penumbra, Inc. Sell -5.68% 0.15%
ALT Altimmune, Inc. Sell -5.55% 2.4%
TDOC Teladoc Health, Inc. Sell -6.16% -0.5%
The percentage of cash held in the portfolio is: 41.52%
New Assets Added
None
Assets Removed
Asset Action Perf %
EDIT Sell All -16.23%
RARE Sell All -2.72%
Assets Rebalanced
None
2024-06-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
RARE Ultragenyx Pharmaceutical Inc. Buy 13.64% 7.42%
AGIO Agios Pharmaceuticals, Inc. Buy 10.81% -1.22%
MDGL Madrigal Pharmaceuticals, Inc. Buy 6.77% 8.69%
ACRS Aclaris Therapeutics, Inc. Buy 15% 6.25%
SGRY Surgery Partners, Inc. Buy 12.84% -4.92%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.88% 2.83%
EDIT Editas Medicine, Inc. Buy 12.27% -9.11%
MASI Masimo Corporation Buy 14.26% 0%
PDSB PDS Biotechnology Corporation Buy 14.26% 0%
MCRB Seres Therapeutics, Inc. Sell -6.94% -15.64%
ABUS Arbutus Biopharma Corporation Sell -5.92% 1.25%
PEN Penumbra, Inc. Sell -5.47% 0.03%
ALT Altimmune, Inc. Sell -5.78% -5.59%
TDOC Teladoc Health, Inc. Sell -5.89% 0%
The percentage of cash held in the portfolio is: 16.26%
New Assets Added
  • MASI
  • PDSB
  • TDOC
Assets Removed
Asset Action Perf %
IRMD Sell All -2.14%
FOLD Sell All 7.79%
ESPR Sell All 27.07%
STAA Buy All -8.41%
Assets Rebalanced
None
2024-06-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
FOLD Amicus Therapeutics, Inc. Buy 13.41% 7.69%
ESPR Esperion Therapeutics, Inc. Buy 15.72% 26.2%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.87% 11.21%
AGIO Agios Pharmaceuticals, Inc. Buy 10.89% 1.31%
MDGL Madrigal Pharmaceuticals, Inc. Buy 6.86% 12.14%
ACRS Aclaris Therapeutics, Inc. Buy 14.23% 2.68%
SGRY Surgery Partners, Inc. Buy 13.26% 0%
IRMD IRadimed Corporation Buy 13.26% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.26% 0%
EDIT Editas Medicine, Inc. Buy 13.26% 0%
STAA STAAR Surgical Company Sell -6.25% -6.18%
MCRB Seres Therapeutics, Inc. Sell -7.15% -21.43%
ABUS Arbutus Biopharma Corporation Sell -5.98% -1.56%
PEN Penumbra, Inc. Sell -5.48% -1.97%
ALT Altimmune, Inc. Sell -5.47% -1.92%
The percentage of cash held in the portfolio is: 2.34%
New Assets Added
  • SGRY
  • IRMD
  • ARWR
  • EDIT
Assets Removed
Asset Action Perf %
MDRX Sell All 0%
ANIK Sell All 1.79%
TVTX Sell All 7.31%
Assets Rebalanced
None
2024-06-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDRX Allscripts Healthcare Solutions, Inc. Buy 12.74% 0%
ANIK Anika Therapeutics, Inc. Buy 12.85% 0.86%
TVTX Travere Therapeutics, Inc. Buy 13.17% 3.36%
FOLD Amicus Therapeutics, Inc. Buy 13.41% 5.26%
ESPR Esperion Therapeutics, Inc. Buy 16.13% 26.64%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.15% 3.14%
AGIO Agios Pharmaceuticals, Inc. Buy 11.03% 0.34%
MDGL Madrigal Pharmaceuticals, Inc. Buy 7.17% 14.56%
ACRS Aclaris Therapeutics, Inc. Buy 14.17% 0%
STAA STAAR Surgical Company Sell -6.03% -0.16%
MCRB Seres Therapeutics, Inc. Sell -7.8% -29.43%
ABUS Arbutus Biopharma Corporation Sell -5.99% 0.62%
PEN Penumbra, Inc. Sell -5.55% -1%
ALT Altimmune, Inc. Sell -5.68% -3.51%
The percentage of cash held in the portfolio is: 17.22%
New Assets Added
  • ACRS
Assets Removed
Asset Action Perf %
DVA Sell All -4.66%
Assets Rebalanced
None
2024-06-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDRX Allscripts Healthcare Solutions, Inc. Buy 12.77% 0.53%
DVA DaVita Inc. Buy 12.26% -3.48%
ANIK Anika Therapeutics, Inc. Buy 12.74% 0.27%
TVTX Travere Therapeutics, Inc. Buy 13.51% 6.29%
FOLD Amicus Therapeutics, Inc. Buy 12.92% 1.72%
ESPR Esperion Therapeutics, Inc. Buy 16.14% 27.07%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.3% 4.56%
AGIO Agios Pharmaceuticals, Inc. Buy 10.93% -0.27%
MDGL Madrigal Pharmaceuticals, Inc. Buy 6.24% 0%
STAA STAAR Surgical Company Sell -5.92% 1.53%
MCRB Seres Therapeutics, Inc. Sell -7.24% -20.52%
ABUS Arbutus Biopharma Corporation Sell -5.89% 1.87%
PEN Penumbra, Inc. Sell -5.48% 0%
ALT Altimmune, Inc. Sell -5.48% 0%
The percentage of cash held in the portfolio is: 19.19%
New Assets Added
  • MDGL
  • PEN
  • ALT
Assets Removed
None
Assets Rebalanced
None
2024-06-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDRX Allscripts Healthcare Solutions, Inc. Buy 12.63% -0.53%
DVA DaVita Inc. Buy 12.39% -2.39%
ANIK Anika Therapeutics, Inc. Buy 12.77% 0.59%
TVTX Travere Therapeutics, Inc. Buy 13.23% 4.24%
FOLD Amicus Therapeutics, Inc. Buy 12.9% 1.72%
ESPR Esperion Therapeutics, Inc. Buy 15.51% 22.27%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.1% 3.14%
AGIO Agios Pharmaceuticals, Inc. Buy 11.01% 0.55%
STAA STAAR Surgical Company Sell -6% 0%
MCRB Seres Therapeutics, Inc. Sell -6% 0%
ABUS Arbutus Biopharma Corporation Sell -6% 0%
The percentage of cash held in the portfolio is: 14.46%
New Assets Added
  • STAA
  • MCRB
  • ABUS
Assets Removed
Asset Action Perf %
TNDM Sell All -5.57%
CUTR Buy All 6.8%
CARA Buy All 7%
CPRX Buy All 1.58%
VERU Buy All 25.2%
SENS Buy All 7.66%
Assets Rebalanced
None
2024-06-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.19% -4.18%
MDRX Allscripts Healthcare Solutions, Inc. Buy 12.85% 0%
DVA DaVita Inc. Buy 12.6% -1.94%
ANIK Anika Therapeutics, Inc. Buy 13.15% 2.34%
TVTX Travere Therapeutics, Inc. Buy 13.58% 5.7%
FOLD Amicus Therapeutics, Inc. Buy 13.34% 3.95%
ESPR Esperion Therapeutics, Inc. Buy 13.85% 7.86%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.38% 4.06%
AGIO Agios Pharmaceuticals, Inc. Buy 11.18% 0.95%
CUTR Cutera, Inc. Sell -5.58% 4.85%
CARA Cara Therapeutics, Inc. Sell -5.62% 4.32%
CPRX Catalyst Pharmaceuticals, Inc. Sell -5.83% 0.69%
VERU Veru Inc. Sell -4.39% 25.2%
SENS Senseonics Holdings, Inc. Sell -5.57% 5.18%
The percentage of cash held in the portfolio is: 13.88%
New Assets Added
None
Assets Removed
Asset Action Perf %
MD Sell All -7.14%
Assets Rebalanced
None
2024-06-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.56% -1.04%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.12% 1.37%
DVA DaVita Inc. Buy 12.65% -2.3%
ANIK Anika Therapeutics, Inc. Buy 13.32% 2.93%
TVTX Travere Therapeutics, Inc. Buy 14.52% 12.13%
FOLD Amicus Therapeutics, Inc. Buy 13.25% 2.43%
ESPR Esperion Therapeutics, Inc. Buy 12.71% -1.75%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.21% 1.94%
MD Pediatrix Medical Group, Inc. Buy 12.76% -1.21%
AGIO Agios Pharmaceuticals, Inc. Buy 11.16% 0%
CUTR Cutera, Inc. Sell -5.97% -0.97%
CARA Cara Therapeutics, Inc. Sell -5.85% 1.04%
CPRX Catalyst Pharmaceuticals, Inc. Sell -5.98% -1.07%
VERU Veru Inc. Sell -4.86% 17.89%
SENS Senseonics Holdings, Inc. Sell -5.6% 5.41%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AGIO
Assets Removed
Asset Action Perf %
VKTX Sell All -13.97%
Assets Rebalanced
None
2024-06-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.58% 0.48%
VKTX Viking Therapeutics, Inc. Buy 12.17% -4.73%
MDRX Allscripts Healthcare Solutions, Inc. Buy 12.91% 1.05%
DVA DaVita Inc. Buy 12.68% -0.74%
ANIK Anika Therapeutics, Inc. Buy 13.3% 4.06%
TVTX Travere Therapeutics, Inc. Buy 14.42% 12.87%
FOLD Amicus Therapeutics, Inc. Buy 12.96% 1.52%
ESPR Esperion Therapeutics, Inc. Buy 12.49% -2.18%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.1% 2.47%
MD Pediatrix Medical Group, Inc. Buy 12.75% 0%
CUTR Cutera, Inc. Sell -6.32% -8.25%
CARA Cara Therapeutics, Inc. Sell -5.92% -1.34%
CPRX Catalyst Pharmaceuticals, Inc. Sell -5.95% -1.95%
VERU Veru Inc. Sell -4.79% 17.89%
SENS Senseonics Holdings, Inc. Sell -5.39% 7.66%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
Assets Removed
None
Assets Rebalanced
None
2024-06-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.64% -0.97%
VKTX Viking Therapeutics, Inc. Buy 12.43% -4.74%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.04% 0%
DVA DaVita Inc. Buy 13.08% 0.29%
ANIK Anika Therapeutics, Inc. Buy 13.05% 0.04%
TVTX Travere Therapeutics, Inc. Buy 14.15% 8.48%
FOLD Amicus Therapeutics, Inc. Buy 12.93% -0.81%
ESPR Esperion Therapeutics, Inc. Buy 12.3% -5.68%
RARE Ultragenyx Pharmaceutical Inc. Buy 13.05% 0%
CUTR Cutera, Inc. Sell -6.22% -4.37%
CARA Cara Therapeutics, Inc. Sell -5.76% 3.28%
CPRX Catalyst Pharmaceuticals, Inc. Sell -6.07% -1.89%
VERU Veru Inc. Sell -4.89% 17.89%
SENS Senseonics Holdings, Inc. Sell -5.77% 3.15%
The percentage of cash held in the portfolio is: 15.05%
New Assets Added
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-05-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.89% 3.29%
VKTX Viking Therapeutics, Inc. Buy 12.13% -5.48%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.19% 2.74%
DVA DaVita Inc. Buy 12.87% 0.31%
ANIK Anika Therapeutics, Inc. Buy 12.87% 0.27%
TVTX Travere Therapeutics, Inc. Buy 13.17% 2.63%
FOLD Amicus Therapeutics, Inc. Buy 12.83% 0%
ESPR Esperion Therapeutics, Inc. Buy 12.83% 0%
CUTR Cutera, Inc. Sell -5.92% -0.97%
CARA Cara Therapeutics, Inc. Sell -5.23% 10.88%
CPRX Catalyst Pharmaceuticals, Inc. Sell -5.95% -1.51%
VERU Veru Inc. Sell -4.62% 21.14%
SENS Senseonics Holdings, Inc. Sell -5.71% 2.7%
The percentage of cash held in the portfolio is: 27.65%
New Assets Added
  • FOLD
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.73% 0.04%
VKTX Viking Therapeutics, Inc. Buy 12.72% -2.37%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.03% 0%
DVA DaVita Inc. Buy 13.03% 0%
ANIK Anika Therapeutics, Inc. Buy 13.03% 0%
TVTX Travere Therapeutics, Inc. Buy 13.03% 0%
CUTR Cutera, Inc. Sell -6.5% -9.22%
CARA Cara Therapeutics, Inc. Sell -5.47% 8.05%
CPRX Catalyst Pharmaceuticals, Inc. Sell -5.96% -0.06%
VERU Veru Inc. Sell -4.84% 18.7%
SENS Senseonics Holdings, Inc. Sell -5.9% 0.9%
The percentage of cash held in the portfolio is: 54.11%
New Assets Added
  • MDRX
  • DVA
  • ANIK
  • TVTX
Assets Removed
None
Assets Rebalanced
None
2024-05-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.94% 2.26%
VKTX Viking Therapeutics, Inc. Buy 13.03% 0%
CUTR Cutera, Inc. Sell -5.84% 1.94%
CARA Cara Therapeutics, Inc. Sell -5.96% -0.15%
CPRX Catalyst Pharmaceuticals, Inc. Sell -6.22% -4.41%
VERU Veru Inc. Sell -5.37% 9.76%
SENS Senseonics Holdings, Inc. Sell -5.83% 2.03%
The percentage of cash held in the portfolio is: 106.25%
New Assets Added
  • VKTX
Assets Removed
None
Assets Rebalanced
None
2024-05-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 9.8% 0%
CUTR Cutera, Inc. Sell -6% 0%
CARA Cara Therapeutics, Inc. Sell -6% 0%
CPRX Catalyst Pharmaceuticals, Inc. Sell -6% 0%
VERU Veru Inc. Sell -6% 0%
SENS Senseonics Holdings, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 120.2%
New Assets Added
  • TNDM
  • CUTR
  • CARA
  • CPRX
  • VERU
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
HCSG Buy All -1.82%
Assets Rebalanced
None
2024-05-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Sell 3.35% 0%
The percentage of cash held in the portfolio is: 96.65%
New Assets Added
None
Assets Removed
Asset Action Perf %
ADUS Sell All 12.14%
Assets Rebalanced
None
2024-05-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ADUS Addus HomeCare Corporation Buy 13.19% 9.52%
HCSG Healthcare Services Group, Inc. Sell 3.31% 1.64%
The percentage of cash held in the portfolio is: 83.5%
New Assets Added
None
Assets Removed
Asset Action Perf %
ANIP Sell All 0.88%
BGNE Sell All 15.52%
CYH Sell All 13.85%
Assets Rebalanced
None
2024-05-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANIP ANI Pharmaceuticals, Inc. Buy 12.38% 1.84%
BGNE BeiGene, Ltd. Buy 14.21% 16.9%
CYH Community Health Systems, Inc. Buy 13.88% 14.19%
ADUS Addus HomeCare Corporation Buy 12.41% 2.5%
HCSG Healthcare Services Group, Inc. Sell 3.33% 1.55%
The percentage of cash held in the portfolio is: 43.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLFS Sell All 8.04%
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 13.14% 4.4%
ANIP ANI Pharmaceuticals, Inc. Buy 12.38% -0.21%
BGNE BeiGene, Ltd. Buy 13.75% 10.76%
CYH Community Health Systems, Inc. Buy 13.84% 11.49%
ADUS Addus HomeCare Corporation Buy 12.45% 0.68%
HCSG Healthcare Services Group, Inc. Sell 3.33% 3.45%
The percentage of cash held in the portfolio is: 31.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
BRKR Sell All -5.4%
TDOC Buy All 2.89%
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 13.42% 6.31%
ANIP ANI Pharmaceuticals, Inc. Buy 12.33% -0.97%
BGNE BeiGene, Ltd. Buy 14.02% 12.62%
BRKR Bruker Corporation Buy 12.27% -1.46%
CYH Community Health Systems, Inc. Buy 13.84% 11.15%
ADUS Addus HomeCare Corporation Buy 12.23% -1.38%
TDOC Teladoc Health, Inc. Sell -20.58% -1.98%
HCSG Healthcare Services Group, Inc. Sell 3.42% 1.27%
The percentage of cash held in the portfolio is: 39.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Sell All -7.14%
AADI Buy All -10.71%
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 12.82% -7.14%
BLFS BioLife Solutions, Inc. Buy 13.14% 4.35%
ANIP ANI Pharmaceuticals, Inc. Buy 12.28% -1.18%
BGNE BeiGene, Ltd. Buy 13.73% 10.5%
BRKR Bruker Corporation Buy 12.2% -1.81%
CYH Community Health Systems, Inc. Buy 14.23% 14.53%
ADUS Addus HomeCare Corporation Buy 12.25% -1.01%
TDOC Teladoc Health, Inc. Sell -19.95% 0.91%
HCSG Healthcare Services Group, Inc. Sell 3.41% 1.36%
AADI Aadi Bioscience, Inc. Sell 3.6% -4.17%
The percentage of cash held in the portfolio is: 22.3%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORMP Buy All -11.82%
Assets Rebalanced
None
2024-04-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 12.55% -10.71%
BLFS BioLife Solutions, Inc. Buy 12.87% 0.36%
ANIP ANI Pharmaceuticals, Inc. Buy 12.42% -1.8%
BGNE BeiGene, Ltd. Buy 13.52% 6.89%
BRKR Bruker Corporation Buy 12.36% -2.27%
CYH Community Health Systems, Inc. Buy 13.89% 9.8%
ADUS Addus HomeCare Corporation Buy 12.1% -3.98%
TDOC Teladoc Health, Inc. Sell -20.81% -1.52%
ORMP Oramed Pharmaceuticals Inc. Sell -19.74% -4.55%
HCSG Healthcare Services Group, Inc. Sell 3.52% 0%
AADI Aadi Bioscience, Inc. Sell 3.52% 0%
The percentage of cash held in the portfolio is: 43.82%
New Assets Added
  • HCSG
  • AADI
Assets Removed
Asset Action Perf %
ATRI Buy All 1.02%
AVNS Buy All 6.89%
BLUE Buy All 21.55%
Assets Rebalanced
None
2024-04-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 12.4% -12.5%
BLFS BioLife Solutions, Inc. Buy 13.22% 2.32%
ANIP ANI Pharmaceuticals, Inc. Buy 12.61% -1.07%
BGNE BeiGene, Ltd. Buy 13.22% 3.69%
BRKR Bruker Corporation Buy 12.71% -0.32%
CYH Community Health Systems, Inc. Buy 13.05% 2.36%
ADUS Addus HomeCare Corporation Buy 12.7% 0%
ATRI Atrion Corporation Sell 12.7% -5.23%
AVNS Avanos Medical, Inc. Sell 3.44% 2.4%
BLUE bluebird bio, Inc. Sell 2.79% 20.69%
TDOC Teladoc Health, Inc. Sell -21.6% -4.57%
ORMP Oramed Pharmaceuticals Inc. Sell -20.5% -7.73%
The percentage of cash held in the portfolio is: 33.27%
New Assets Added
  • ATRI
  • ADUS
Assets Removed
None
Assets Rebalanced
None
2024-04-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 13.13% -7.14%
BLFS BioLife Solutions, Inc. Buy 13.07% 1.31%
CYH Community Health Systems, Inc. Buy 12.72% 0%
BRKR Bruker Corporation Buy 12.72% 0%
BGNE BeiGene, Ltd. Buy 12.72% 0%
ANIP ANI Pharmaceuticals, Inc. Buy 12.72% 0%
ATRI Atrion Corporation Sell 3.53% -0.54%
AVNS Avanos Medical, Inc. Sell 3.44% 2.14%
BLUE bluebird bio, Inc. Sell 2.94% 16.38%
TDOC Teladoc Health, Inc. Sell -21.58% -4.65%
ORMP Oramed Pharmaceuticals Inc. Sell -20.29% -6.82%
The percentage of cash held in the portfolio is: 54.86%
New Assets Added
  • CYH
  • BRKR
  • BGNE
  • ANIP
Assets Removed
Asset Action Perf %
KIDS Sell All 0.76%
Assets Rebalanced
None
2024-04-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
KIDS OrthoPediatrics Corp. Buy 12.15% -0.66%
SGMO Sangamo Therapeutics, Inc. Buy 12.86% -8.93%
BLFS BioLife Solutions, Inc. Buy 12.87% 0%
ATRI Atrion Corporation Sell 3.48% 0.81%
AVNS Avanos Medical, Inc. Sell 3.47% 1.15%
BLUE bluebird bio, Inc. Sell 2.87% 18.1%
TDOC Teladoc Health, Inc. Sell -20.85% -1.29%
ORMP Oramed Pharmaceuticals Inc. Sell -20.08% -5.91%
The percentage of cash held in the portfolio is: 93.23%
New Assets Added
  • BLFS
Assets Removed
Asset Action Perf %
ORGO Sell All 0%
PODD Sell All -3.31%
Assets Rebalanced
None
2024-04-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.99% -3.7%
PODD Insulet Corporation Buy 11.33% -3.12%
KIDS OrthoPediatrics Corp. Buy 11.86% -3.09%
SGMO Sangamo Therapeutics, Inc. Buy 12.36% -12.5%
ATRI Atrion Corporation Sell 3.36% 4.32%
AVNS Avanos Medical, Inc. Sell 3.42% 2.45%
BLUE bluebird bio, Inc. Sell 2.87% 18.1%
TDOC Teladoc Health, Inc. Sell -20.68% -0.38%
ORMP Oramed Pharmaceuticals Inc. Sell -18.98% 0%
The percentage of cash held in the portfolio is: 82.46%
New Assets Added
  • ORMP
Assets Removed
Asset Action Perf %
MDGL Sell All -10.86%
GKOS Sell All -5.47%
CDXS Buy All 12.77%
Assets Rebalanced
None
2024-04-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.55% -3.7%
GKOS Glaukos Corporation Buy 11.29% -3.66%
PODD Insulet Corporation Buy 11.45% 1.57%
KIDS OrthoPediatrics Corp. Buy 11.71% -0.72%
MDGL Madrigal Pharmaceuticals, Inc. Buy 11.02% -6.56%
SGMO Sangamo Therapeutics, Inc. Buy 13.13% -3.57%
CDXS Codexis, Inc. Sell -19.76% 14.95%
ATRI Atrion Corporation Sell 3.43% -1.5%
AVNS Avanos Medical, Inc. Sell 3.29% 2.71%
BLUE bluebird bio, Inc. Sell 2.89% 14.66%
TDOC Teladoc Health, Inc. Sell -19.85% 0%
The percentage of cash held in the portfolio is: 59.85%
New Assets Added
  • TDOC
Assets Removed
Asset Action Perf %
NKTR Sell All -10.78%
SMTI Buy All 10.11%
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.04% -7.07%
GKOS Glaukos Corporation Buy 11.16% -3.77%
PODD Insulet Corporation Buy 11.41% 2.29%
KIDS OrthoPediatrics Corp. Buy 11.69% 0.16%
MDGL Madrigal Pharmaceuticals, Inc. Buy 10.83% -7.21%
NKTR Nektar Therapeutics Buy 16.78% -5.99%
SGMO Sangamo Therapeutics, Inc. Buy 13.48% 0%
SMTI Sanara MedTech Inc. Sell -19.13% 8.41%
CDXS Codexis, Inc. Sell -19.27% 16.2%
ATRI Atrion Corporation Sell 3.31% 1.1%
AVNS Avanos Medical, Inc. Sell 3.29% 1.67%
BLUE bluebird bio, Inc. Sell 2.97% 11.21%
The percentage of cash held in the portfolio is: 42.43%
New Assets Added
  • SGMO
Assets Removed
Asset Action Perf %
SAVA Sell All -15.1%
TDOC Sell All -10.03%
BCRX Sell All -8.43%
Assets Rebalanced
None
2024-04-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.23% -3.03%
GKOS Glaukos Corporation Buy 11.04% -2.38%
PODD Insulet Corporation Buy 11.21% 3.05%
SAVA Cassava Sciences, Inc. Buy 10.2% -3.48%
TDOC Teladoc Health, Inc. Buy 10.75% -5.64%
KIDS OrthoPediatrics Corp. Buy 11.65% 2.27%
MDGL Madrigal Pharmaceuticals, Inc. Buy 10.81% -5.11%
BCRX BioCryst Pharmaceuticals, Inc. Buy 16.25% -6.47%
NKTR Nektar Therapeutics Buy 17.41% 0%
SMTI Sanara MedTech Inc. Sell -19.4% 4.8%
CDXS Codexis, Inc. Sell -20.05% 10.59%
ATRI Atrion Corporation Sell 3.24% 0.93%
AVNS Avanos Medical, Inc. Sell 3.15% 3.44%
BLUE bluebird bio, Inc. Sell 3.1% 5.17%
The percentage of cash held in the portfolio is: 19.41%
New Assets Added
  • NKTR
Assets Removed
None
Assets Rebalanced
None
2024-04-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 11.32% 1.01%
GKOS Glaukos Corporation Buy 10.8% -1.36%
PODD Insulet Corporation Buy 11.12% 5.65%
SAVA Cassava Sciences, Inc. Buy 11.33% 10.78%
TDOC Teladoc Health, Inc. Buy 10.69% -3.05%
KIDS OrthoPediatrics Corp. Buy 11.44% 3.82%
MDGL Madrigal Pharmaceuticals, Inc. Buy 10.84% -1.63%
BCRX BioCryst Pharmaceuticals, Inc. Buy 16.82% 0%
SMTI Sanara MedTech Inc. Sell -18.45% 6.42%
CDXS Codexis, Inc. Sell -21.03% 3.12%
ATRI Atrion Corporation Sell 3.16% 0%
AVNS Avanos Medical, Inc. Sell 3.16% 0%
BLUE bluebird bio, Inc. Sell 3.16% 0%
The percentage of cash held in the portfolio is: 35.63%
New Assets Added
  • BCRX
  • ATRI
  • AVNS
  • BLUE
Assets Removed
Asset Action Perf %
VERU Sell All 115.66%
ALPN Sell All 65.38%
Assets Rebalanced
None
2024-04-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
VERU Veru Inc. Buy 13.16% 49.4%
ORGO Organogenesis Holdings Inc. Buy 12.55% -0.67%
GKOS Glaukos Corporation Buy 12.23% -0.91%
PODD Insulet Corporation Buy 12.38% 4.33%
SAVA Cassava Sciences, Inc. Buy 11.99% 3.99%
TDOC Teladoc Health, Inc. Buy 11.96% -3.72%
KIDS OrthoPediatrics Corp. Buy 12.98% 4.51%
MDGL Madrigal Pharmaceuticals, Inc. Buy 12.19% -1.87%
ALPN Alpine Immune Sciences, Inc. Buy 15.01% 20.8%
SMTI Sanara MedTech Inc. Sell -20.83% 6.25%
CDXS Codexis, Inc. Sell -23.85% 2.49%
The percentage of cash held in the portfolio is: 30.24%
New Assets Added
None
Assets Removed
Asset Action Perf %
SLP Sell All 0.65%
Assets Rebalanced
None
2024-04-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
VERU Veru Inc. Buy 12.8% 40.96%
SLP Simulations Plus, Inc. Buy 12.8% 6.71%
ORGO Organogenesis Holdings Inc. Buy 12.8% -1.68%
GKOS Glaukos Corporation Buy 12.8% 0.68%
PODD Insulet Corporation Buy 12.8% 4.69%
SAVA Cassava Sciences, Inc. Buy 12.8% 7.76%
TDOC Teladoc Health, Inc. Buy 12.8% 0%
KIDS OrthoPediatrics Corp. Buy 12.8% 0%
MDGL Madrigal Pharmaceuticals, Inc. Buy 12.8% 0%
ALPN Alpine Immune Sciences, Inc. Buy 12.8% 0%
SMTI Sanara MedTech Inc. Sell -21.73% 5.11%
CDXS Codexis, Inc. Sell -25.36% -0.62%
The percentage of cash held in the portfolio is: 19.09%
New Assets Added
  • TDOC
  • KIDS
  • MDGL
  • ALPN
Assets Removed
Asset Action Perf %
NUTX Buy All -1356.33%
Assets Rebalanced
Asset Action Weight
ORGO Sell -32.43%
GKOS Sell -33.51%
PODD Sell -35.36%
SAVA Sell -36.77%
SLP Sell -38.74%
VERU Sell -55.16%
2024-04-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
VERU Veru Inc. Buy 15.21% 24.1%
SLP Simulations Plus, Inc. Buy 12.77% 3.95%
GKOS Glaukos Corporation Buy 11.7% 0%
PODD Insulet Corporation Buy 11.7% 0%
SAVA Cassava Sciences, Inc. Buy 11.7% 0%
ORGO Organogenesis Holdings Inc. Buy 11.7% 0%
SMTI Sanara MedTech Inc. Sell -5.62% 3.44%
CDXS Codexis, Inc. Sell -6.41% 0%
NUTX Nutex Health Inc. Sell -5.55% 3.67%
The percentage of cash held in the portfolio is: 42.82%
New Assets Added
  • GKOS
  • PODD
  • SAVA
  • ORGO
Assets Removed
Asset Action Perf %
HROW Sell All 10.08%
RGEN Buy All 5.86%
Assets Rebalanced
None
2024-04-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
HROW Harrow Health, Inc. Buy 13.9% 12.58%
VERU Veru Inc. Buy 13.98% 12.05%
SLP Simulations Plus, Inc. Buy 12.54% 0.34%
RGEN Repligen Corporation Sell -6.07% 5.99%
SMTI Sanara MedTech Inc. Sell -5.71% 3.64%
CDXS Codexis, Inc. Sell -6.48% 0.62%
NUTX Nutex Health Inc. Sell -5.87% 0%
The percentage of cash held in the portfolio is: 83.71%
New Assets Added
  • NUTX
Assets Removed
Asset Action Perf %
CUTR Buy All 2.5%
BGNE Buy All 1.31%
Assets Rebalanced
None
2024-04-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
HROW Harrow Health, Inc. Buy 13.74% 9.58%
VERU Veru Inc. Buy 12.67% 0%
SLP Simulations Plus, Inc. Buy 12.7% 0%
CUTR Cutera, Inc. Sell -5.46% 9.37%
BGNE BeiGene, Ltd. Sell -5.93% 1.61%
RGEN Repligen Corporation Sell -6.14% 6.46%
SMTI Sanara MedTech Inc. Sell -5.85% 2.9%
CDXS Codexis, Inc. Sell -6.63% 0%
The percentage of cash held in the portfolio is: 90.88%
New Assets Added
  • SLP
  • CDXS
Assets Removed
Asset Action Perf %
ATRI Buy All -10.11%
Assets Rebalanced
None
2024-04-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
HROW Harrow Health, Inc. Buy 13.72% 9.17%
VERU Veru Inc. Buy 12.7% 0%
CUTR Cutera, Inc. Sell -5.47% 9.37%
BGNE BeiGene, Ltd. Sell -6.04% 0.05%
RGEN Repligen Corporation Sell -6.3% 4.09%
SMTI Sanara MedTech Inc. Sell -5.97% 1.08%
ATRI Atrion Corporation Sell -6.41% -6.36%
The percentage of cash held in the portfolio is: 103.78%
New Assets Added
  • VERU
Assets Removed
None
Assets Rebalanced
None
2024-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
HROW Harrow Health, Inc. Buy 13.02% 3.17%
CUTR Cutera, Inc. Sell -5.42% 10.63%
BGNE BeiGene, Ltd. Sell -6.11% -0.81%
RGEN Repligen Corporation Sell -6.35% 3.76%
SMTI Sanara MedTech Inc. Sell -6.06% 0%
ATRI Atrion Corporation Sell -6.06% 0%
The percentage of cash held in the portfolio is: 116.98%
New Assets Added
  • SMTI
  • ATRI
Assets Removed
Asset Action Perf %
TNDM Sell All 8.77%
CHRS Sell All -3.67%
SMMT Buy All -6.06%
Assets Rebalanced
None
2024-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 13.93% 14.61%
CHRS Coherus BioSciences, Inc. Buy 12% -1.22%
HROW Harrow Health, Inc. Buy 13.21% 6.08%
SMMT Summit Therapeutics Inc. Sell -5.65% -3.31%
CUTR Cutera, Inc. Sell -5.28% 11.88%
BGNE BeiGene, Ltd. Sell -6.11% -2.01%
RGEN Repligen Corporation Sell -6.51% 0.07%
The percentage of cash held in the portfolio is: 84.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVXL Buy All -11.21%
Assets Rebalanced
None
2024-03-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 13.44% 9.38%
CHRS Coherus BioSciences, Inc. Buy 11.43% -6.94%
HROW Harrow Health, Inc. Buy 13.2% 4.83%
SMMT Summit Therapeutics Inc. Sell -5.7% -3.03%
CUTR Cutera, Inc. Sell -5.33% 11.88%
BGNE BeiGene, Ltd. Sell -6.12% -1.18%
RGEN Repligen Corporation Sell -6.55% 0.56%
AVXL Anavex Life Sciences Corp. Sell -7.01% -6.37%
The percentage of cash held in the portfolio is: 92.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
MD Sell All 2.46%
CORT Sell All 1.19%
IBRX Sell All -14.52%
Assets Rebalanced
None
2024-03-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
MD Pediatrix Medical Group, Inc. Buy 14.74% -0.85%
CORT Corcept Therapeutics Incorporated Buy 14.99% 0.82%
TNDM Tandem Diabetes Care, Inc. Buy 12.13% -2.27%
CHRS Coherus BioSciences, Inc. Buy 11.55% -6.94%
IBRX ImmunityBio, Inc. Buy 10.25% -9.18%
HROW Harrow Health, Inc. Buy 12.72% 0%
SMMT Summit Therapeutics Inc. Sell -5.05% 9.64%
CUTR Cutera, Inc. Sell -5.46% 10.63%
BGNE BeiGene, Ltd. Sell -6.19% -1.25%
RGEN Repligen Corporation Sell -6.65% 0%
AVXL Anavex Life Sciences Corp. Sell -6.65% 0%
The percentage of cash held in the portfolio is: 53.63%
New Assets Added
  • HROW
  • RGEN
  • AVXL
Assets Removed
Asset Action Perf %
INO Sell All 2.99%
BCRX Sell All -10.24%
SMTI Buy All 0.68%
MCRB Buy All 8.49%
Assets Rebalanced
None
2024-03-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
INO Inovio Pharmaceuticals, Inc. Buy 12.23% -3.49%
MD Pediatrix Medical Group, Inc. Buy 14.8% -0.43%
CORT Corcept Therapeutics Incorporated Buy 14.88% 0.16%
TNDM Tandem Diabetes Care, Inc. Buy 12.18% -1.75%
CHRS Coherus BioSciences, Inc. Buy 11.79% -4.9%
IBRX ImmunityBio, Inc. Buy 11.43% 1.34%
BCRX BioCryst Pharmaceuticals, Inc. Buy 10.33% -8.41%
SMTI Sanara MedTech Inc. Sell -6.73% -2.49%
MCRB Seres Therapeutics, Inc. Sell -5.87% 10.58%
SMMT Summit Therapeutics Inc. Sell -5.18% 7.16%
CUTR Cutera, Inc. Sell -6.11% 0%
BGNE BeiGene, Ltd. Sell -6.11% 0%
The percentage of cash held in the portfolio is: 42.37%
New Assets Added
  • CUTR
  • BGNE
Assets Removed
Asset Action Perf %
ARDX Buy All 11.39%
Assets Rebalanced
None
2024-03-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
INO Inovio Pharmaceuticals, Inc. Buy 11.28% -10.38%
MD Pediatrix Medical Group, Inc. Buy 15.15% 2.67%
CORT Corcept Therapeutics Incorporated Buy 14.73% -0.2%
TNDM Tandem Diabetes Care, Inc. Buy 12.98% 5.39%
CHRS Coherus BioSciences, Inc. Buy 12.47% 1.22%
IBRX ImmunityBio, Inc. Buy 11.2% 0%
BCRX BioCryst Pharmaceuticals, Inc. Buy 11.2% 0%
ARDX Ardelyx, Inc. Sell -5.73% 10.24%
SMTI Sanara MedTech Inc. Sell -6.74% -3.26%
MCRB Seres Therapeutics, Inc. Sell -6.3% 3.37%
SMMT Summit Therapeutics Inc. Sell -5.85% -5.51%
The percentage of cash held in the portfolio is: 35.61%
New Assets Added
  • IBRX
  • BCRX
Assets Removed
None
Assets Rebalanced
None
2024-03-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
INO Inovio Pharmaceuticals, Inc. Buy 11.25% -11.3%
MD Pediatrix Medical Group, Inc. Buy 15.07% 1.28%
CORT Corcept Therapeutics Incorporated Buy 14.75% -0.86%
TNDM Tandem Diabetes Care, Inc. Buy 12.42% 0%
CHRS Coherus BioSciences, Inc. Buy 12.42% 0%
ARDX Ardelyx, Inc. Sell -5.94% 7.71%
SMTI Sanara MedTech Inc. Sell -6.71% -2.03%
MCRB Seres Therapeutics, Inc. Sell -6.16% 6.28%
SMMT Summit Therapeutics Inc. Sell -5.59% 0%
The percentage of cash held in the portfolio is: 58.49%
New Assets Added
  • TNDM
  • CHRS
  • SMMT
Assets Removed
Asset Action Perf %
MDXG Buy All -0.63%
RCKT Buy All 2.47%
Assets Rebalanced
None
2024-03-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
INO Inovio Pharmaceuticals, Inc. Buy 11.2% -10.96%
MD Pediatrix Medical Group, Inc. Buy 14.84% 0.53%
CORT Corcept Therapeutics Incorporated Buy 14.67% -0.61%
MDXG MiMedx Group, Inc. Sell -6.38% 1.5%
RCKT Rocket Pharmaceuticals, Inc. Sell -6.23% 3.74%
ARDX Ardelyx, Inc. Sell -5.76% 9.78%
SMTI Sanara MedTech Inc. Sell -6.51% 0.25%
MCRB Seres Therapeutics, Inc. Sell -5.75% 11.86%
The percentage of cash held in the portfolio is: 89.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVXL Sell All -11.56%
NSTG Sell All -48.32%
ABUS Sell All -6.62%
Assets Rebalanced
None
2024-03-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AVXL Anavex Life Sciences Corp. Buy 10.58% -4.59%
INO Inovio Pharmaceuticals, Inc. Buy 11.24% -4.4%
NSTG NanoString Technologies, Inc. Buy 11.23% -4.44%
ABUS Arbutus Biopharma Corporation Buy 11.62% -1.1%
MD Pediatrix Medical Group, Inc. Buy 13.79% 0%
CORT Corcept Therapeutics Incorporated Buy 13.79% 0%
MDXG MiMedx Group, Inc. Sell -6.04% 0.13%
RCKT Rocket Pharmaceuticals, Inc. Sell -5.94% 1.78%
ARDX Ardelyx, Inc. Sell -5.78% 3.11%
SMTI Sanara MedTech Inc. Sell -6.15% -0.96%
MCRB Seres Therapeutics, Inc. Sell -5.48% 10.12%
The percentage of cash held in the portfolio is: 57.15%
New Assets Added
  • MD
  • CORT
Assets Removed
None
Assets Rebalanced
None
2024-03-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
AVXL Anavex Life Sciences Corp. Buy 10.52% -4.77%
INO Inovio Pharmaceuticals, Inc. Buy 11.71% 0%
NSTG NanoString Technologies, Inc. Buy 11.71% 0%
ABUS Arbutus Biopharma Corporation Buy 11.71% 0%
MDXG MiMedx Group, Inc. Sell -6.02% 0%
RCKT Rocket Pharmaceuticals, Inc. Sell -6.03% -0.18%
ARDX Ardelyx, Inc. Sell -5.8% 2.3%
SMTI Sanara MedTech Inc. Sell -6.07% 0%
MCRB Seres Therapeutics, Inc. Sell -6.07% 0%
The percentage of cash held in the portfolio is: 84.37%
New Assets Added
  • INO
  • NSTG
  • ABUS
  • SMTI
  • MCRB
Assets Removed
None
Assets Rebalanced
None
2024-03-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
AVXL Anavex Life Sciences Corp. Buy 11.02% 0%
MDXG MiMedx Group, Inc. Sell -6.13% -2%
RCKT Rocket Pharmaceuticals, Inc. Sell -6.08% -1.16%
ARDX Ardelyx, Inc. Sell -5.93% 0%
The percentage of cash held in the portfolio is: 107.12%
New Assets Added
  • AVXL
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-03-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDXG MiMedx Group, Inc. Sell -6% 0%
RCKT Rocket Pharmaceuticals, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 112%
New Assets Added
  • MDXG
  • RCKT
Assets Removed
None
Assets Rebalanced
None
2024-02-13 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CBAY Sell All 35.68%
Assets Rebalanced
None
2024-02-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
CBAY CymaBay Therapeutics, Inc. Buy 14.36% 8.21%
The percentage of cash held in the portfolio is: 85.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALPN Sell All 15.61%
PODD Buy All 1.49%
Assets Rebalanced
None
2024-02-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALPN Alpine Immune Sciences, Inc. Buy 10.58% 13.1%
CBAY CymaBay Therapeutics, Inc. Buy 14.05% 5.14%
PODD Insulet Corporation Sell -4.91% -0.6%
The percentage of cash held in the portfolio is: 80.28%
New Assets Added
None
Assets Removed
Asset Action Perf %
SAVA Buy All -2.73%
Assets Rebalanced
None
2024-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALPN Alpine Immune Sciences, Inc. Buy 9.96% 5.57%
CBAY CymaBay Therapeutics, Inc. Buy 13.77% 2.15%
SAVA Cassava Sciences, Inc. Sell -5.42% 3.74%
PODD Insulet Corporation Sell -5.03% -2.13%
The percentage of cash held in the portfolio is: 86.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORMP Sell All 23.58%
CHRS Buy All 3.33%
Assets Rebalanced
None
2024-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORMP Oramed Pharmaceuticals Inc. Buy 13.06% 14.41%
ALPN Alpine Immune Sciences, Inc. Buy 10.29% 9.28%
CBAY CymaBay Therapeutics, Inc. Buy 13.53% 0.51%
CHRS Coherus BioSciences, Inc. Sell -4.94% 15.83%
SAVA Cassava Sciences, Inc. Sell -5.24% 6.79%
PODD Insulet Corporation Sell -4.87% 0.98%
The percentage of cash held in the portfolio is: 78.17%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All 6.45%
NVCR Sell All -11.36%
SGMO Buy All -33.33%
Assets Rebalanced
None
2024-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGEN Repligen Corporation Buy 12.24% 6.49%
ORMP Oramed Pharmaceuticals Inc. Buy 13.78% 20.09%
ALPN Alpine Immune Sciences, Inc. Buy 10.44% 10.23%
CBAY CymaBay Therapeutics, Inc. Buy 13.57% 0.34%
NVCR NovoCure Limited Buy 12.31% -8.97%
CHRS Coherus BioSciences, Inc. Sell -5.07% 14.17%
SAVA Cassava Sciences, Inc. Sell -5.47% 3.21%
SGMO Sangamo Therapeutics, Inc. Sell 8.72% -16.67%
PODD Insulet Corporation Sell -4.91% 0.74%
The percentage of cash held in the portfolio is: 44.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVTA Buy All 9.32%
Assets Rebalanced
None
2024-02-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGEN Repligen Corporation Buy 11.92% 4.61%
ORMP Oramed Pharmaceuticals Inc. Buy 14.06% 23.58%
ALPN Alpine Immune Sciences, Inc. Buy 10.46% 11.39%
CBAY CymaBay Therapeutics, Inc. Buy 13.78% 2.74%
NVCR NovoCure Limited Buy 12.69% -5.36%
NVTA Invitae Corporation Sell 11.22% 11.66%
CHRS Coherus BioSciences, Inc. Sell -5.1% 12.92%
SAVA Cassava Sciences, Inc. Sell -5.44% 3.01%
SGMO Sangamo Therapeutics, Inc. Sell 8.82% -19.05%
PODD Insulet Corporation Sell -4.9% 0.03%
The percentage of cash held in the portfolio is: 32.48%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACRS Sell All 1.69%
Assets Rebalanced
None
2024-01-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 11.8% 2.54%
RGEN Repligen Corporation Buy 12.15% 5.03%
ORMP Oramed Pharmaceuticals Inc. Buy 15.03% 30.13%
ALPN Alpine Immune Sciences, Inc. Buy 9.76% 2.43%
CBAY CymaBay Therapeutics, Inc. Buy 13.56% -0.38%
NVCR NovoCure Limited Buy 12.32% -9.49%
SGMO Sangamo Therapeutics, Inc. Sell 8.24% -9.52%
NVTA Invitae Corporation Sell 12.2% 5.36%
CHRS Coherus BioSciences, Inc. Sell -5.72% 3.75%
SAVA Cassava Sciences, Inc. Sell -5.7% -0.28%
PODD Insulet Corporation Sell -4.89% 1.71%
The percentage of cash held in the portfolio is: 21.26%
New Assets Added
  • SGMO
Assets Removed
Asset Action Perf %
SMMT Sell All 8.82%
Assets Rebalanced
None
2024-01-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
SMMT Summit Therapeutics Inc. Buy 12.43% 8.96%
ACRS Aclaris Therapeutics, Inc. Buy 11.8% 3.39%
RGEN Repligen Corporation Buy 11.97% 4.34%
ORMP Oramed Pharmaceuticals Inc. Buy 12.91% 12.66%
ALPN Alpine Immune Sciences, Inc. Buy 9.82% 3.9%
CBAY CymaBay Therapeutics, Inc. Buy 13.5% 0%
NVCR NovoCure Limited Buy 13.5% 0%
NVTA Invitae Corporation Sell 13.5% -5.59%
CHRS Coherus BioSciences, Inc. Sell -5.64% 4.17%
SAVA Cassava Sciences, Inc. Sell -5.72% -1.34%
PODD Insulet Corporation Sell -5.03% -2%
SGMO Sangamo Therapeutics, Inc. Sell -5.29% -7.14%
The percentage of cash held in the portfolio is: 22.25%
New Assets Added
  • NVCR
  • CBAY
  • NVTA
Assets Removed
Asset Action Perf %
FGEN Sell All 76.29%
Assets Rebalanced
None
2024-01-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
SMMT Summit Therapeutics Inc. Buy 14.07% 12.14%
ACRS Aclaris Therapeutics, Inc. Buy 13.08% 4.24%
RGEN Repligen Corporation Buy 13.24% 4.98%
ORMP Oramed Pharmaceuticals Inc. Buy 12.76% 1.31%
FGEN FibroGen, Inc. Buy 12.04% -3.51%
ALPN Alpine Immune Sciences, Inc. Buy 10.39% 0%
NVTA Invitae Corporation Sell -6.72% 4.43%
CHRS Coherus BioSciences, Inc. Sell -6.31% 2.5%
SAVA Cassava Sciences, Inc. Sell -6.12% 1.42%
PODD Insulet Corporation Sell -5.43% 0%
SGMO Sangamo Therapeutics, Inc. Sell -5.43% 0%
The percentage of cash held in the portfolio is: 54.41%
New Assets Added
  • ALPN
  • PODD
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-01-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
SMMT Summit Therapeutics Inc. Buy 15.83% 31.5%
ACRS Aclaris Therapeutics, Inc. Buy 12.76% 5.93%
RGEN Repligen Corporation Buy 12.19% 0.7%
ORMP Oramed Pharmaceuticals Inc. Buy 11.98% -0.87%
FGEN FibroGen, Inc. Buy 13.58% 13.4%
NVTA Invitae Corporation Sell -6.01% 10.96%
CHRS Coherus BioSciences, Inc. Sell -6.14% 1.25%
SAVA Cassava Sciences, Inc. Sell -5.95% 0%
The percentage of cash held in the portfolio is: 51.76%
New Assets Added
  • SAVA
Assets Removed
Asset Action Perf %
NSTG Buy All 11.36%
NKTR Buy All 5.56%
VERU Buy All 0%
Assets Rebalanced
None
2024-01-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
SMMT Summit Therapeutics Inc. Buy 15.75% 28.03%
ACRS Aclaris Therapeutics, Inc. Buy 13.14% 6.78%
RGEN Repligen Corporation Buy 12.2% -1.34%
ORMP Oramed Pharmaceuticals Inc. Buy 12.24% -0.87%
FGEN FibroGen, Inc. Buy 12.24% 0%
NSTG NanoString Technologies, Inc. Sell -5.26% 9.09%
NKTR Nektar Therapeutics Sell -5.46% 5.56%
VERU Veru Inc. Sell -5.65% 2.27%
NVTA Invitae Corporation Sell -6.32% 8.39%
CHRS Coherus BioSciences, Inc. Sell -6.09% 4.17%
The percentage of cash held in the portfolio is: 63.2%
New Assets Added
  • FGEN
Assets Removed
Asset Action Perf %
ALGN Sell All -5.35%
Assets Rebalanced
None
2024-01-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
SMMT Summit Therapeutics Inc. Buy 14.69% 18.21%
ACRS Aclaris Therapeutics, Inc. Buy 13.49% 8.47%
RGEN Repligen Corporation Buy 12.69% 1.54%
ALGN Align Technology, Inc. Buy 12.26% -1.91%
ORMP Oramed Pharmaceuticals Inc. Buy 12.48% 0%
NSTG NanoString Technologies, Inc. Sell -5.85% 0%
NKTR Nektar Therapeutics Sell -5.52% 5.56%
VERU Veru Inc. Sell -5.45% 6.82%
NVTA Invitae Corporation Sell -6.77% 2.8%
CHRS Coherus BioSciences, Inc. Sell -6.42% 0%
The percentage of cash held in the portfolio is: 64.39%
New Assets Added
  • ORMP
  • CHRS
Assets Removed
Asset Action Perf %
PDSB Buy All -11.53%
Assets Rebalanced
None
2024-01-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
SMMT Summit Therapeutics Inc. Buy 13.67% 8.96%
ACRS Aclaris Therapeutics, Inc. Buy 13.4% 6.78%
RGEN Repligen Corporation Buy 12.61% 0%
ALGN Align Technology, Inc. Buy 12.61% 0%
NSTG NanoString Technologies, Inc. Sell -6.17% -4.55%
PDSB PDS Biotechnology Corporation Sell -5.87% 0.44%
NKTR Nektar Therapeutics Sell -5.57% 5.56%
VERU Veru Inc. Sell -5.36% 9.09%
NVTA Invitae Corporation Sell -7.02% 0.23%
The percentage of cash held in the portfolio is: 77.69%
New Assets Added
  • RGEN
  • ALGN
Assets Removed
None
Assets Rebalanced
None
2024-01-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
SMMT Summit Therapeutics Inc. Buy 13.28% 4.34%
ACRS Aclaris Therapeutics, Inc. Buy 12.3% -3.39%
NSTG NanoString Technologies, Inc. Sell -5.99% 0%
PDSB PDS Biotechnology Corporation Sell -5.97% 0.22%
NKTR Nektar Therapeutics Sell -5.87% 1.85%
VERU Veru Inc. Sell -5.03% 15.91%
NVTA Invitae Corporation Sell -7.13% 0%
The percentage of cash held in the portfolio is: 104.42%
New Assets Added
  • NVTA
Assets Removed
Asset Action Perf %
AXGN Buy All -9.75%
Assets Rebalanced
None
2024-01-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
SMMT Summit Therapeutics Inc. Buy 12.24% -4.34%
ACRS Aclaris Therapeutics, Inc. Buy 12.8% 0%
AXGN AxoGen, Inc. Sell -6.12% -1.75%
NSTG NanoString Technologies, Inc. Sell -5.74% 4.55%
PDSB PDS Biotechnology Corporation Sell -5.72% 4.88%
NKTR Nektar Therapeutics Sell -6.13% -1.85%
VERU Veru Inc. Sell -5.74% 4.55%
The percentage of cash held in the portfolio is: 104.42%
New Assets Added
  • ACRS
Assets Removed
None
Assets Rebalanced
None
2024-01-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
SMMT Summit Therapeutics Inc. Buy 12.62% 0%
AXGN AxoGen, Inc. Sell -5.9% 0.63%
NSTG NanoString Technologies, Inc. Sell -5.53% 6.82%
PDSB PDS Biotechnology Corporation Sell -5.37% 9.42%
NKTR Nektar Therapeutics Sell -5.71% 3.7%
VERU Veru Inc. Sell -5.66% 4.55%
The percentage of cash held in the portfolio is: 115.56%
New Assets Added
  • SMMT
Assets Removed
None
Assets Rebalanced
None
2024-01-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Sell -5.91% 1.25%
NSTG NanoString Technologies, Inc. Sell -5.44% 9.09%
PDSB PDS Biotechnology Corporation Sell -5.73% 4.21%
NKTR Nektar Therapeutics Sell -5.87% 1.85%
VERU Veru Inc. Sell -6.25% -4.55%
The percentage of cash held in the portfolio is: 129.19%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All -3.82%
Assets Rebalanced
None
2024-01-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
STAA STAAR Surgical Company Buy 9.8% 0%
AXGN AxoGen, Inc. Sell -6% 0%
NSTG NanoString Technologies, Inc. Sell -6% 0%
PDSB PDS Biotechnology Corporation Sell -6% 0%
NKTR Nektar Therapeutics Sell -6% 0%
VERU Veru Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 120.2%
New Assets Added
  • STAA
  • AXGN
  • NSTG
  • PDSB
  • NKTR
  • VERU
Assets Removed
None
Assets Rebalanced
None
2023-11-15 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
SLP Sell All 8.87%
TDOC Sell All 3.08%
NUTX Sell All 13.48%
IART Sell All 9.01%
CERS Sell All 25.71%
Assets Rebalanced
None
2023-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
SLP Simulations Plus, Inc. Buy 11.58% 3.49%
TDOC Teladoc Health, Inc. Buy 10.6% -5.32%
NUTX Nutex Health Inc. Buy 13.57% 21.26%
IART Integra LifeSciences Holdings Corporation Buy 11.39% 1.78%
CERS Cerus Corporation Buy 12.63% 12.86%
The percentage of cash held in the portfolio is: 40.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
MODV Sell All -1.58%
ITGR Sell All 7.11%
ACRS Sell All -87.05%
Assets Rebalanced
None
2023-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 10.35% 0.43%
ITGR Integer Holdings Corporation Buy 10.85% 5.26%
SLP Simulations Plus, Inc. Buy 10.42% 1.11%
TDOC Teladoc Health, Inc. Buy 9.94% -3.57%
NUTX Nutex Health Inc. Buy 11.95% 15.94%
IART Integra LifeSciences Holdings Corporation Buy 10.36% 0.56%
ACRS Aclaris Therapeutics, Inc. Buy 9.84% -4.52%
CERS Cerus Corporation Buy 11.78% 14.29%
The percentage of cash held in the portfolio is: 14.51%
New Assets Added
None
Assets Removed
Asset Action Perf %
OFIX Sell All -9.42%
Assets Rebalanced
None
2023-11-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 10.07% 2.7%
ITGR Integer Holdings Corporation Buy 10.21% 4.13%
SLP Simulations Plus, Inc. Buy 9.69% -1.13%
TDOC Teladoc Health, Inc. Buy 10.04% 2.36%
NUTX Nutex Health Inc. Buy 13.26% 35.27%
IART Integra LifeSciences Holdings Corporation Buy 10.31% 5.12%
OFIX Orthofix Medical Inc. Buy 10.38% 5.89%
ACRS Aclaris Therapeutics, Inc. Buy 9.98% 1.81%
CERS Cerus Corporation Buy 11.13% 13.57%
The percentage of cash held in the portfolio is: 4.93%
New Assets Added
None
Assets Removed
Asset Action Perf %
MNKD Sell All -7.23%
ISRG Buy All -7.08%
Assets Rebalanced
None
2023-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 10.5% 1.1%
ITGR Integer Holdings Corporation Buy 10.48% 0.96%
SLP Simulations Plus, Inc. Buy 10.38% 0%
TDOC Teladoc Health, Inc. Buy 10.38% 0%
NUTX Nutex Health Inc. Buy 10.38% 0%
IART Integra LifeSciences Holdings Corporation Buy 10.38% 0%
OFIX Orthofix Medical Inc. Buy 10.38% 0%
MNKD MannKind Corporation Buy 10.38% 0%
ACRS Aclaris Therapeutics, Inc. Buy 10.38% 0%
CERS Cerus Corporation Buy 10.38% 0%
ISRG Intuitive Surgical, Inc. Sell -6.05% -1.04%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SLP
  • TDOC
  • NUTX
  • IART
  • OFIX
  • MNKD
  • ACRS
  • CERS
Assets Removed
None
Assets Rebalanced
None
2023-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 10.4% 0%
ITGR Integer Holdings Corporation Buy 10.4% 0%
ISRG Intuitive Surgical, Inc. Sell -5.98% 0.39%
The percentage of cash held in the portfolio is: 85.18%
New Assets Added
  • MODV
  • ITGR
Assets Removed
None
Assets Rebalanced
None
2023-10-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ISRG Intuitive Surgical, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 106%
New Assets Added
  • ISRG
Assets Removed
None
Assets Rebalanced
None
2023-10-20 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -4.18%
ANIP Sell All -2.25%
Assets Rebalanced
None
2023-10-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
MGNX MacroGenics, Inc. Buy 20.26% 7.11%
ANIP ANI Pharmaceuticals, Inc. Buy 18.52% -2.11%
The percentage of cash held in the portfolio is: 61.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
QTRX Buy All 24.68%
Assets Rebalanced
None
2023-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
MGNX MacroGenics, Inc. Buy 20.39% 8.16%
ANIP ANI Pharmaceuticals, Inc. Buy 18.83% -0.09%
QTRX Quanterix Corporation Sell -5.43% 21.43%
The percentage of cash held in the portfolio is: 66.21%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All 1.45%
LGND Buy All 4.65%
RGNX Buy All -1.12%
BCRX Buy All 12.26%
Assets Rebalanced
None
2023-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 15.94% -6.76%
MGNX MacroGenics, Inc. Buy 20.37% 6.07%
ANIP ANI Pharmaceuticals, Inc. Buy 18.88% -1.65%
LGND Ligand Pharmaceuticals Incorporated Sell -5.63% 7.06%
RGNX REGENXBIO Inc. Sell -6.07% -0.12%
BCRX BioCryst Pharmaceuticals, Inc. Sell -5.32% 12.26%
QTRX Quanterix Corporation Sell -5.5% 21.93%
The percentage of cash held in the portfolio is: 67.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
AZTA Sell All -0.32%
CYH Sell All -9.66%
BGNE Buy All 0.6%
Assets Rebalanced
None
2023-10-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AZTA Azenta, Inc. Buy 10.16% 0.66%
CYH Community Health Systems, Inc. Buy 9.29% -7.93%
NUTX Nutex Health Inc. Buy 15.6% -9.18%
MGNX MacroGenics, Inc. Buy 19.97% 3.56%
ANIP ANI Pharmaceuticals, Inc. Buy 19.06% -1.18%
BGNE BeiGene, Ltd. Sell -5.9% 2.02%
LGND Ligand Pharmaceuticals Incorporated Sell -5.69% 6.62%
RGNX REGENXBIO Inc. Sell -6.03% 1%
BCRX BioCryst Pharmaceuticals, Inc. Sell -5.38% 11.67%
QTRX Quanterix Corporation Sell -5.52% 21.97%
The percentage of cash held in the portfolio is: 54.43%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDRX Sell All 1.35%
Assets Rebalanced
None
2023-10-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.42% 3.66%
AZTA Azenta, Inc. Buy 10.32% 2.53%
CYH Community Health Systems, Inc. Buy 9.69% -3.79%
NUTX Nutex Health Inc. Buy 15.65% -8.7%
MGNX MacroGenics, Inc. Buy 20.45% 6.28%
ANIP ANI Pharmaceuticals, Inc. Buy 19.77% 2.73%
BGNE BeiGene, Ltd. Sell -6.08% -1.3%
LGND Ligand Pharmaceuticals Incorporated Sell -6.04% 0.51%
RGNX REGENXBIO Inc. Sell -6.36% -4.6%
BCRX BioCryst Pharmaceuticals, Inc. Sell -5.74% 5.47%
QTRX Quanterix Corporation Sell -6.2% 12.24%
The percentage of cash held in the portfolio is: 44.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All -10.63%
Assets Rebalanced
None
2023-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.49% 3.74%
AZTA Azenta, Inc. Buy 10.37% 2.43%
CYH Community Health Systems, Inc. Buy 10.2% 0.69%
OPK OPKO Health, Inc. Buy 9.5% -6.25%
NUTX Nutex Health Inc. Buy 15.65% -9.18%
MGNX MacroGenics, Inc. Buy 20.33% 5.02%
ANIP ANI Pharmaceuticals, Inc. Buy 19.53% 0.87%
BGNE BeiGene, Ltd. Sell -5.93% 1.78%
LGND Ligand Pharmaceuticals Incorporated Sell -6.23% -1.99%
RGNX REGENXBIO Inc. Sell -6.4% -4.67%
BCRX BioCryst Pharmaceuticals, Inc. Sell -5.78% 5.47%
QTRX Quanterix Corporation Sell -7.06% 0.57%
The percentage of cash held in the portfolio is: 35.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
CPSI Sell All 6.02%
ARDX Sell All 1.97%
Assets Rebalanced
None
2023-10-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
CPSI Computer Programs and Systems, Inc. Buy 12.38% 5.95%
ARDX Ardelyx, Inc. Buy 11.4% -2.46%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.7% 3.81%
AZTA Azenta, Inc. Buy 10.34% 0.18%
CYH Community Health Systems, Inc. Buy 9.89% -4.14%
OPK OPKO Health, Inc. Buy 9.67% -6.25%
NUTX Nutex Health Inc. Buy 16.12% -8.21%
MGNX MacroGenics, Inc. Buy 19.51% -1.05%
ANIP ANI Pharmaceuticals, Inc. Buy 19.53% -0.96%
BGNE BeiGene, Ltd. Sell -5.91% 3.94%
LGND Ligand Pharmaceuticals Incorporated Sell -6.19% 0.56%
RGNX REGENXBIO Inc. Sell -6.23% 0%
BCRX BioCryst Pharmaceuticals, Inc. Sell -5.66% 9.16%
QTRX Quanterix Corporation Sell -7.24% -0.04%
The percentage of cash held in the portfolio is: 11.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
AXGN Sell All -13.44%
Assets Rebalanced
None
2023-10-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
CPSI Computer Programs and Systems, Inc. Buy 12.73% 11.06%
ARDX Ardelyx, Inc. Buy 11.4% -0.49%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.4% 2.91%
AXGN AxoGen, Inc. Buy 9.42% -6.72%
AZTA Azenta, Inc. Buy 9.98% -1.37%
CYH Community Health Systems, Inc. Buy 9.63% -4.83%
OPK OPKO Health, Inc. Buy 9.55% -5.63%
NUTX Nutex Health Inc. Buy 16.22% -5.8%
MGNX MacroGenics, Inc. Buy 19.34% 0%
ANIP ANI Pharmaceuticals, Inc. Buy 19.34% 0%
BGNE BeiGene, Ltd. Sell -5.72% 5.11%
LGND Ligand Pharmaceuticals Incorporated Sell -6% 1.77%
RGNX REGENXBIO Inc. Sell -6.01% 1.49%
BCRX BioCryst Pharmaceuticals, Inc. Sell -5.98% 2.07%
QTRX Quanterix Corporation Sell -7% 1.33%
The percentage of cash held in the portfolio is: 2.71%
New Assets Added
  • MGNX
  • ANIP
Assets Removed
Asset Action Perf %
VCEL Sell All -0.44%
Assets Rebalanced
None
2023-10-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 10.69% -0.73%
CPSI Computer Programs and Systems, Inc. Buy 12.44% 9.18%
ARDX Ardelyx, Inc. Buy 11.33% -0.49%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.18% 1.42%
AXGN AxoGen, Inc. Buy 9.53% -5.14%
AZTA Azenta, Inc. Buy 9.91% -1.45%
CYH Community Health Systems, Inc. Buy 9.95% -1.03%
OPK OPKO Health, Inc. Buy 9.43% -6.25%
NUTX Nutex Health Inc. Buy 16.12% -5.8%
BGNE BeiGene, Ltd. Sell -5.64% 5.96%
LGND Ligand Pharmaceuticals Incorporated Sell -5.98% 1.42%
RGNX REGENXBIO Inc. Sell -5.72% 5.66%
BCRX BioCryst Pharmaceuticals, Inc. Sell -5.6% 7.68%
QTRX Quanterix Corporation Sell -7.05% 0%
The percentage of cash held in the portfolio is: 30.41%
New Assets Added
  • QTRX
Assets Removed
Asset Action Perf %
KURA Buy All 9.44%
Assets Rebalanced
None
2023-10-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 10.81% -1.46%
CPSI Computer Programs and Systems, Inc. Buy 12% 3.43%
ARDX Ardelyx, Inc. Buy 11.4% -1.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.15% -0.75%
AXGN AxoGen, Inc. Buy 9.93% -2.96%
AZTA Azenta, Inc. Buy 9.98% -2.61%
CYH Community Health Systems, Inc. Buy 10.24% 0%
OPK OPKO Health, Inc. Buy 9.54% -6.88%
NUTX Nutex Health Inc. Buy 16.51% -5.31%
KURA Kura Oncology, Inc. Sell -5.82% 8.11%
BGNE BeiGene, Ltd. Sell -5.92% 3.13%
LGND Ligand Pharmaceuticals Incorporated Sell -6.14% 0.71%
RGNX REGENXBIO Inc. Sell -6.35% -2.68%
BCRX BioCryst Pharmaceuticals, Inc. Sell -5.86% 5.17%
The percentage of cash held in the portfolio is: 29.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Sell All -22.92%
Assets Rebalanced
None
2023-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 10.42% -2.92%
CPSI Computer Programs and Systems, Inc. Buy 12.01% 5.82%
ARDX Ardelyx, Inc. Buy 11.35% 0%
FGEN FibroGen, Inc. Buy 9.58% -15.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.91% -1.05%
AXGN AxoGen, Inc. Buy 9.89% -1.19%
AZTA Azenta, Inc. Buy 9.94% -0.84%
CYH Community Health Systems, Inc. Buy 10.09% 0.69%
OPK OPKO Health, Inc. Buy 9.59% -4.38%
NUTX Nutex Health Inc. Buy 17.06% 0%
KURA Kura Oncology, Inc. Sell -5.92% 4.44%
BGNE BeiGene, Ltd. Sell -5.93% 0.76%
LGND Ligand Pharmaceuticals Incorporated Sell -6.05% 0%
RGNX REGENXBIO Inc. Sell -6.05% 0%
BCRX BioCryst Pharmaceuticals, Inc. Sell -6.05% 0%
The percentage of cash held in the portfolio is: 20.15%
New Assets Added
  • NUTX
  • LGND
  • RGNX
  • BCRX
Assets Removed
Asset Action Perf %
QTRX Sell All -2.48%
Assets Rebalanced
None
2023-10-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 10.46% -1.96%
CPSI Computer Programs and Systems, Inc. Buy 11.63% 3.1%
ARDX Ardelyx, Inc. Buy 11.34% 0.49%
QTRX Quanterix Corporation Buy 11.18% -0.91%
FGEN FibroGen, Inc. Buy 10.14% -10.1%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.77% -1.79%
AXGN AxoGen, Inc. Buy 9.83% -1.19%
AZTA Azenta, Inc. Buy 9.96% 0%
CYH Community Health Systems, Inc. Buy 9.96% 0%
OPK OPKO Health, Inc. Buy 9.96% 0%
KURA Kura Oncology, Inc. Sell -6.24% -1.33%
BGNE BeiGene, Ltd. Sell -5.94% 0%
The percentage of cash held in the portfolio is: 7.94%
New Assets Added
  • AZTA
  • CYH
  • OPK
  • BGNE
Assets Removed
None
Assets Rebalanced
None
2023-09-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 10.41% -0.29%
CPSI Computer Programs and Systems, Inc. Buy 11.34% 2.72%
ARDX Ardelyx, Inc. Buy 10.99% -0.49%
QTRX Quanterix Corporation Buy 11.27% 2.08%
FGEN FibroGen, Inc. Buy 11.18% 1.25%
MDRX Allscripts Healthcare Solutions, Inc. Buy 9.74% 0%
AXGN AxoGen, Inc. Buy 9.74% 0%
KURA Kura Oncology, Inc. Sell -5.87% 2.56%
The percentage of cash held in the portfolio is: 31.21%
New Assets Added
  • MDRX
  • AXGN
Assets Removed
None
Assets Rebalanced
None
2023-09-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 10.82% 3.89%
CPSI Computer Programs and Systems, Inc. Buy 11.18% 1.55%
ARDX Ardelyx, Inc. Buy 11.23% 1.97%
QTRX Quanterix Corporation Buy 11.01% 0%
FGEN FibroGen, Inc. Buy 11.01% 0%
KURA Kura Oncology, Inc. Sell -5.79% 3.67%
The percentage of cash held in the portfolio is: 50.54%
New Assets Added
  • QTRX
  • FGEN
Assets Removed
Asset Action Perf %
FOLD Buy All -7.69%
Assets Rebalanced
None
2023-09-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 10.26% -2.02%
CPSI Computer Programs and Systems, Inc. Buy 11.07% 0%
ARDX Ardelyx, Inc. Buy 11.07% 0%
KURA Kura Oncology, Inc. Sell -5.66% 6.22%
FOLD Amicus Therapeutics, Inc. Sell -6.22% -2.34%
The percentage of cash held in the portfolio is: 79.49%
New Assets Added
  • CPSI
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2023-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 10.39% -0.56%
KURA Kura Oncology, Inc. Sell -5.74% 4.78%
FOLD Amicus Therapeutics, Inc. Sell -6.07% 0%
The percentage of cash held in the portfolio is: 101.41%
New Assets Added
  • FOLD
Assets Removed
Asset Action Perf %
ATXS Buy All -11.47%
Assets Rebalanced
None
2023-09-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 10.4% 0%
KURA Kura Oncology, Inc. Sell -6.02% -0.33%
ATXS Astria Therapeutics, Inc. Sell -5.99% 0%
The percentage of cash held in the portfolio is: 101.61%
New Assets Added
  • VCEL
  • ATXS
Assets Removed
None
Assets Rebalanced
None
2023-09-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
KURA Kura Oncology, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 106%
New Assets Added
  • KURA
Assets Removed
None
Assets Rebalanced
None
2023-09-11 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATXS Sell All -1.73%
IONS Sell All 2.21%
FOLD Sell All -2.26%
Assets Rebalanced
None
2023-09-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 14.24% 2.76%
IONS Ionis Pharmaceuticals, Inc. Buy 13.68% -1.31%
FOLD Amicus Therapeutics, Inc. Buy 13.74% -0.86%
The percentage of cash held in the portfolio is: 58.35%
New Assets Added
None
Assets Removed
Asset Action Perf %
QTRX Sell All 5.73%
Assets Rebalanced
None
2023-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
QTRX Quanterix Corporation Buy 14.59% 3.84%
ATXS Astria Therapeutics, Inc. Buy 14.16% 1.5%
IONS Ionis Pharmaceuticals, Inc. Buy 13.62% -2.43%
FOLD Amicus Therapeutics, Inc. Buy 13.73% -1.63%
The percentage of cash held in the portfolio is: 43.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All -11.74%
IOVA Sell All -5.33%
Assets Rebalanced
None
2023-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 11.26% -5.79%
IOVA Iovance Biotherapeutics, Inc. Buy 11.52% -3.61%
QTRX Quanterix Corporation Buy 14.82% 8.01%
ATXS Astria Therapeutics, Inc. Buy 13.99% 2.65%
IONS Ionis Pharmaceuticals, Inc. Buy 13.69% 0.45%
FOLD Amicus Therapeutics, Inc. Buy 13.69% 0.47%
The percentage of cash held in the portfolio is: 21.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
AXGN Sell All NA
EGRX Sell All NA
Assets Rebalanced
None
2023-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 13.65% 5.35%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.78% -1.33%
AADI Aadi Bioscience, Inc. Buy 11.26% -5.79%
IOVA Iovance Biotherapeutics, Inc. Buy 11.52% -3.61%
QTRX Quanterix Corporation Buy 14.82% 8.01%
ATXS Astria Therapeutics, Inc. Buy 13.99% 2.65%
IONS Ionis Pharmaceuticals, Inc. Buy 13.69% 0.45%
FOLD Amicus Therapeutics, Inc. Buy 13.69% 0.47%
The percentage of cash held in the portfolio is: -5.41%
New Assets Added
None
Assets Removed
Asset Action Perf %
INSM Buy All -4.19%
CDNA Buy All -15.7%
Assets Rebalanced
None
2023-08-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 13.58% 6.86%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.2% -3.99%
AADI Aadi Bioscience, Inc. Buy 12.58% 7.4%
IOVA Iovance Biotherapeutics, Inc. Buy 11.31% -3.45%
QTRX Quanterix Corporation Buy 14.23% 5.73%
ATXS Astria Therapeutics, Inc. Buy 13.84% 3.57%
IONS Ionis Pharmaceuticals, Inc. Buy 13.45% 0.62%
FOLD Amicus Therapeutics, Inc. Buy 13.67% 2.26%
INSM Insmed Incorporated Sell -6.14% -1.61%
CDNA CareDx, Inc Sell -6.68% -10.7%
The percentage of cash held in the portfolio is: 7.97%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -7.59%
VERU Buy All -1.85%
Assets Rebalanced
None
2023-08-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 14.11% 11.04%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12% -5.59%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.94% -6.04%
AADI Aadi Bioscience, Inc. Buy 12.64% 7.88%
IOVA Iovance Biotherapeutics, Inc. Buy 11.24% -4.08%
QTRX Quanterix Corporation Buy 13.69% 1.68%
ATXS Astria Therapeutics, Inc. Buy 13.55% 1.38%
IONS Ionis Pharmaceuticals, Inc. Buy 13.61% 1.84%
FOLD Amicus Therapeutics, Inc. Buy 13.42% 0.39%
VERU Veru Inc. Sell -5.74% 0.93%
INSM Insmed Incorporated Sell -6.01% 0.55%
CDNA CareDx, Inc Sell -6.59% -9.16%
The percentage of cash held in the portfolio is: 2.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Buy All -9.06%
Assets Rebalanced
None
2023-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 13.61% 6.86%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.33% -3.2%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.59% -9.03%
AADI Aadi Bioscience, Inc. Buy 12.84% 9.32%
IOVA Iovance Biotherapeutics, Inc. Buy 11.26% -4.08%
QTRX Quanterix Corporation Buy 13.61% 0.92%
ATXS Astria Therapeutics, Inc. Buy 13.51% 0.81%
IONS Ionis Pharmaceuticals, Inc. Buy 13.58% 1.34%
FOLD Amicus Therapeutics, Inc. Buy 13.36% -0.31%
VERU Veru Inc. Sell -5.65% 2.78%
RGEN Repligen Corporation Sell -6.37% -5.27%
INSM Insmed Incorporated Sell -6.02% 0.51%
CDNA CareDx, Inc Sell -6.38% -5.35%
The percentage of cash held in the portfolio is: 8.74%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Buy All -17.22%
Assets Rebalanced
None
2023-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 13.34% 6.02%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.13% -3.6%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.82% -6.09%
AADI Aadi Bioscience, Inc. Buy 13.3% 14.63%
IOVA Iovance Biotherapeutics, Inc. Buy 11.19% -3.61%
QTRX Quanterix Corporation Buy 13.24% -0.68%
ATXS Astria Therapeutics, Inc. Buy 13.24% 0%
IONS Ionis Pharmaceuticals, Inc. Buy 13.24% 0%
FOLD Amicus Therapeutics, Inc. Buy 13.24% 0%
VERU Veru Inc. Sell -5.47% 4.63%
RGEN Repligen Corporation Sell -6.25% -4.42%
INSM Insmed Incorporated Sell -6.01% -0.51%
CDNA CareDx, Inc Sell -6.21% -3.8%
PDSB PDS Biotechnology Corporation Sell -7.6% -9.34%
The percentage of cash held in the portfolio is: 16.78%
New Assets Added
  • ATXS
  • IONS
  • FOLD
Assets Removed
None
Assets Rebalanced
None
2023-08-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 13.39% 5.69%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.21% -3.6%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.3% -2.94%
AADI Aadi Bioscience, Inc. Buy 12.41% 6.27%
IOVA Iovance Biotherapeutics, Inc. Buy 11.13% -4.7%
QTRX Quanterix Corporation Buy 13.22% -1.48%
VERU Veru Inc. Sell -5.51% 4.63%
RGEN Repligen Corporation Sell -6.23% -3.4%
INSM Insmed Incorporated Sell -6.08% -0.92%
CDNA CareDx, Inc Sell -6.24% -3.57%
PDSB PDS Biotechnology Corporation Sell -7.48% -6.96%
The percentage of cash held in the portfolio is: 56.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVAX Sell All 1.98%
Assets Rebalanced
None
2023-08-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 13.66% 9.03%
BCRX BioCryst Pharmaceuticals, Inc. Buy 11.88% -5.19%
NVAX Novavax, Inc. Buy 13.99% 11.65%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.31% -1.77%
AADI Aadi Bioscience, Inc. Buy 11.65% 0.8%
IOVA Iovance Biotherapeutics, Inc. Buy 11.43% -1.1%
QTRX Quanterix Corporation Buy 13.27% 0%
VERU Veru Inc. Sell -5.5% 3.7%
RGEN Repligen Corporation Sell -6.28% -5.4%
INSM Insmed Incorporated Sell -6.05% -1.66%
CDNA CareDx, Inc Sell -6.21% -4.28%
PDSB PDS Biotechnology Corporation Sell -7.61% -10.07%
The percentage of cash held in the portfolio is: 43.47%
New Assets Added
  • QTRX
Assets Removed
Asset Action Perf %
VKTX Sell All -1.71%
Assets Rebalanced
None
2023-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
VKTX Viking Therapeutics, Inc. Buy 12.97% -1.51%
AXGN AxoGen, Inc. Buy 13.19% 6.86%
BCRX BioCryst Pharmaceuticals, Inc. Buy 11.92% -3.46%
NVAX Novavax, Inc. Buy 14.01% 13.51%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.17% -1.44%
AADI Aadi Bioscience, Inc. Buy 11.38% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 11.38% 0%
VERU Veru Inc. Sell -5.47% 2.78%
RGEN Repligen Corporation Sell -6.02% -2.54%
INSM Insmed Incorporated Sell -5.85% 0.37%
CDNA CareDx, Inc Sell -5.85% 0.36%
PDSB PDS Biotechnology Corporation Sell -6.82% 0%
The percentage of cash held in the portfolio is: 42.97%
New Assets Added
  • AADI
  • IOVA
  • PDSB
Assets Removed
Asset Action Perf %
NTRA Sell All 1.95%
Assets Rebalanced
None
2023-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTRA Natera, Inc. Buy 14.02% 4.17%
VKTX Viking Therapeutics, Inc. Buy 13.11% -2.54%
AXGN AxoGen, Inc. Buy 12.61% 0%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.61% 0%
NVAX Novavax, Inc. Buy 12.61% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.61% 0%
VERU Veru Inc. Sell -5.7% 0.93%
RGEN Repligen Corporation Sell -6.11% -2.01%
INSM Insmed Incorporated Sell -6.07% -1.24%
CDNA CareDx, Inc Sell -6.14% -2.5%
The percentage of cash held in the portfolio is: 46.46%
New Assets Added
  • AXGN
  • BCRX
  • NVAX
  • EGRX
Assets Removed
Asset Action Perf %
MD Sell All 0%
SYK Sell All -3.5%
MOH Buy All -3.29%
Assets Rebalanced
None
2023-08-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
MD Pediatrix Medical Group, Inc. Buy 13.57% 0.61%
SYK Stryker Corporation Buy 13.09% -2.92%
NTRA Natera, Inc. Buy 13.46% -0.23%
VKTX Viking Therapeutics, Inc. Buy 12.92% -4.18%
VERU Veru Inc. Sell -5.76% 0%
MOH Molina Healthcare, Inc. Sell -6.21% -1.43%
RGEN Repligen Corporation Sell -6.01% 0%
INSM Insmed Incorporated Sell -6.01% 0%
CDNA CareDx, Inc Sell -6.01% 0%
The percentage of cash held in the portfolio is: 76.96%
New Assets Added
  • RGEN
  • INSM
  • CDNA
Assets Removed
Asset Action Perf %
GEN Sell All 1.34%
DVAX Sell All -0.14%
Assets Rebalanced
None
2023-08-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
GEN Gen Digital Inc. Buy 13.65% 0.3%
DVAX Dynavax Technologies Corporation Buy 13.43% -1.31%
MD Pediatrix Medical Group, Inc. Buy 13.51% 0.13%
SYK Stryker Corporation Buy 13.1% -2.91%
NTRA Natera, Inc. Buy 13.3% -1.42%
VKTX Viking Therapeutics, Inc. Buy 13.07% -3.08%
VERU Veru Inc. Sell -5.5% 4.63%
MOH Molina Healthcare, Inc. Sell -6.13% 0%
The percentage of cash held in the portfolio is: 31.56%
New Assets Added
  • MOH
Assets Removed
Asset Action Perf %
NUTX Sell All -21.05%
BRKR Sell All -8.6%
LMAT Buy All 3.62%
Assets Rebalanced
None
2023-08-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
GEN Gen Digital Inc. Buy 13.65% 1.84%
DVAX Dynavax Technologies Corporation Buy 13.09% -2.28%
MD Pediatrix Medical Group, Inc. Buy 13.03% -1.89%
SYK Stryker Corporation Buy 13.06% -1.63%
NTRA Natera, Inc. Buy 13.43% 1.12%
VKTX Viking Therapeutics, Inc. Buy 12.92% -2.67%
NUTX Nutex Health Inc. Buy 10.86% -13.16%
BRKR Bruker Corporation Buy 11.8% -4.24%
LMAT LeMaitre Vascular, Inc. Sell -7.3% 2.71%
VERU Veru Inc. Sell -5.67% 0%
The percentage of cash held in the portfolio is: 11.13%
New Assets Added
  • VERU
Assets Removed
Asset Action Perf %
OMI Sell All -6.63%
IOVA Sell All -9.21%
NSTG Buy All 26.37%
EXAS Buy All 0.83%
LNTH Buy All 18.44%
NVTA Buy All 17.74%
Assets Rebalanced
None
2023-08-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
GEN Gen Digital Inc. Buy 13.72% 4.78%
DVAX Dynavax Technologies Corporation Buy 12.9% -1.52%
MD Pediatrix Medical Group, Inc. Buy 12.73% -1.95%
SYK Stryker Corporation Buy 12.91% -0.52%
NTRA Natera, Inc. Buy 14.01% 7.95%
OMI Owens & Minor, Inc. Buy 12.51% -3.59%
VKTX Viking Therapeutics, Inc. Buy 13.07% 0.69%
IOVA Iovance Biotherapeutics, Inc. Buy 12.16% -6.32%
NUTX Nutex Health Inc. Buy 10.8% -11.58%
BRKR Bruker Corporation Buy 12.05% 0%
NSTG NanoString Technologies, Inc. Sell -4.87% 20.37%
EXAS Exact Sciences Corporation Sell -6.11% 0.06%
LNTH Lantheus Holdings, Inc. Sell -5.16% 15.62%
NVTA Invitae Corporation Sell -5.47% 10.48%
LMAT LeMaitre Vascular, Inc. Sell -7.25% 1.12%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BRKR
Assets Removed
Asset Action Perf %
OFIX Sell All -7.62%
Assets Rebalanced
None
2023-08-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
GEN Gen Digital Inc. Buy 13.2% 3.78%
DVAX Dynavax Technologies Corporation Buy 12.54% -1.38%
MD Pediatrix Medical Group, Inc. Buy 12.53% -0.61%
SYK Stryker Corporation Buy 12.42% -1.45%
NTRA Natera, Inc. Buy 13.44% 6.62%
OMI Owens & Minor, Inc. Buy 12.49% -0.88%
OFIX Orthofix Medical Inc. Buy 12.34% -2.11%
VKTX Viking Therapeutics, Inc. Buy 13.04% 3.5%
IOVA Iovance Biotherapeutics, Inc. Buy 11.71% -7.11%
NUTX Nutex Health Inc. Buy 11.86% 0%
NSTG NanoString Technologies, Inc. Sell -4.76% 19.84%
EXAS Exact Sciences Corporation Sell -5.74% 3.24%
LNTH Lantheus Holdings, Inc. Sell -5% 15.67%
NVTA Invitae Corporation Sell -5.12% 13.71%
LMAT LeMaitre Vascular, Inc. Sell -6.95% 2.45%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NUTX
Assets Removed
Asset Action Perf %
AVXL Sell All -5.87%
Assets Rebalanced
None
2023-08-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
GEN Gen Digital Inc. Buy 13.18% 3.73%
DVAX Dynavax Technologies Corporation Buy 12.58% -0.97%
MD Pediatrix Medical Group, Inc. Buy 12.47% -0.94%
SYK Stryker Corporation Buy 12.41% -1.49%
NTRA Natera, Inc. Buy 12.48% -0.89%
OMI Owens & Minor, Inc. Buy 12.59% 0%
OFIX Orthofix Medical Inc. Buy 12.59% 0%
VKTX Viking Therapeutics, Inc. Buy 12.59% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 12.59% 0%
AVXL Anavex Life Sciences Corp. Buy 12.59% 0%
NSTG NanoString Technologies, Inc. Sell -4.97% 16.19%
EXAS Exact Sciences Corporation Sell -5.73% 3.39%
LNTH Lantheus Holdings, Inc. Sell -4.99% 15.89%
NVTA Invitae Corporation Sell -5.31% 10.48%
LMAT LeMaitre Vascular, Inc. Sell -7.1% 0.26%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OMI
  • OFIX
  • VKTX
  • IOVA
  • AVXL
Assets Removed
None
Assets Rebalanced
None
2023-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
GEN Gen Digital Inc. Buy 12.94% 0.9%
DVAX Dynavax Technologies Corporation Buy 13.17% 2.69%
MD Pediatrix Medical Group, Inc. Buy 12.59% -1.01%
SYK Stryker Corporation Buy 12.54% -1.38%
NTRA Natera, Inc. Buy 12.72% 0%
NSTG NanoString Technologies, Inc. Sell -5.49% 8.36%
EXAS Exact Sciences Corporation Sell -5.94% 0.74%
LNTH Lantheus Holdings, Inc. Sell -5.15% 13.95%
NVTA Invitae Corporation Sell -5.79% 3.23%
LMAT LeMaitre Vascular, Inc. Sell -7.17% 0.19%
The percentage of cash held in the portfolio is: 65.58%
New Assets Added
  • NTRA
Assets Removed
None
Assets Rebalanced
None
2023-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
GEN Gen Digital Inc. Buy 13.41% 5.07%
DVAX Dynavax Technologies Corporation Buy 12.99% 1.72%
MD Pediatrix Medical Group, Inc. Buy 12.65% 0%
SYK Stryker Corporation Buy 12.65% 0%
NSTG NanoString Technologies, Inc. Sell -5.58% 6.27%
EXAS Exact Sciences Corporation Sell -5.95% 0.07%
LNTH Lantheus Holdings, Inc. Sell -5.26% 11.61%
NVTA Invitae Corporation Sell -5.62% 5.65%
LMAT LeMaitre Vascular, Inc. Sell -7.2% -0.68%
The percentage of cash held in the portfolio is: 77.91%
New Assets Added
  • MD
  • SYK
Assets Removed
Asset Action Perf %
BCRX Sell All -11.71%
Assets Rebalanced
None
2023-08-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
GEN Gen Digital Inc. Buy 12.8% 0%
DVAX Dynavax Technologies Corporation Buy 12.8% 0%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.8% 0%
NSTG NanoString Technologies, Inc. Sell -6.03% -1.04%
EXAS Exact Sciences Corporation Sell -5.98% -0.16%
LNTH Lantheus Holdings, Inc. Sell -5.52% 7.49%
NVTA Invitae Corporation Sell -5.92% 0.81%
LMAT LeMaitre Vascular, Inc. Sell -7.12% 0.61%
The percentage of cash held in the portfolio is: 92.19%
New Assets Added
  • GEN
  • DVAX
  • BCRX
Assets Removed
None
Assets Rebalanced
None
2023-08-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
NSTG NanoString Technologies, Inc. Sell -5.53% 7.05%
EXAS Exact Sciences Corporation Sell -6.13% -3.16%
LNTH Lantheus Holdings, Inc. Sell -5.31% 10.71%
NVTA Invitae Corporation Sell -5.9% 0.81%
LMAT LeMaitre Vascular, Inc. Sell -7.14% 0%
The percentage of cash held in the portfolio is: 130%
New Assets Added
  • LMAT
Assets Removed
None
Assets Rebalanced
None
2023-08-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
NSTG NanoString Technologies, Inc. Sell -6% 0%
EXAS Exact Sciences Corporation Sell -6% 0%
LNTH Lantheus Holdings, Inc. Sell -6% 0%
NVTA Invitae Corporation Sell -6% 0%
The percentage of cash held in the portfolio is: 124%
New Assets Added
  • NSTG
  • EXAS
  • LNTH
  • NVTA
Assets Removed
None
Assets Rebalanced
None
2023-07-28 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
INSM Sell All -2.72%
MTD Sell All -0.27%
HQY Buy All -2.82%
Assets Rebalanced
None
2023-07-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
INSM Insmed Incorporated Buy 13.01% -2.91%
MTD Mettler-Toledo International Inc. Buy 13.48% 0.55%
HQY HealthEquity, Inc. Sell -6.13% -1.88%
The percentage of cash held in the portfolio is: 79.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Sell All 9.62%
CUTR Sell All -6.6%
Assets Rebalanced
None
2023-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
SMTI Sanara MedTech Inc. Buy 7.77% 5.65%
CUTR Cutera, Inc. Buy 6.91% -6.04%
INSM Insmed Incorporated Buy 12.98% -3.58%
MTD Mettler-Toledo International Inc. Buy 13.32% -1.12%
HQY HealthEquity, Inc. Sell -6.06% -0.28%
The percentage of cash held in the portfolio is: 65.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
KIDS Sell All -1.45%
BCRX Buy All -7.15%
Assets Rebalanced
None
2023-07-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
KIDS OrthoPediatrics Corp. Buy 11.36% 2.64%
SMTI Sanara MedTech Inc. Buy 7.54% 4.62%
CUTR Cutera, Inc. Buy 7.37% 2.26%
INSM Insmed Incorporated Buy 13.3% 0.67%
MTD Mettler-Toledo International Inc. Buy 13.33% 0.93%
HQY HealthEquity, Inc. Sell -6.09% -2.64%
BCRX BioCryst Pharmaceuticals, Inc. Sell -6.13% -3.23%
The percentage of cash held in the portfolio is: 59.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
DVA Sell All 3.35%
BLUE Buy All -10.88%
Assets Rebalanced
None
2023-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
DVA DaVita Inc. Buy 16.25% 3.13%
KIDS OrthoPediatrics Corp. Buy 11.36% 3.36%
SMTI Sanara MedTech Inc. Buy 7.32% 2.24%
CUTR Cutera, Inc. Buy 7.24% 1.19%
INSM Insmed Incorporated Buy 12.95% -1.29%
MTD Mettler-Toledo International Inc. Buy 13.12% 0.05%
HQY HealthEquity, Inc. Sell -5.88% 0.11%
BLUE bluebird bio, Inc. Sell -5.53% 6.04%
BCRX BioCryst Pharmaceuticals, Inc. Sell -5.94% -0.84%
The percentage of cash held in the portfolio is: 49.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Sell All -2.22%
AMN Buy All -3.11%
PACB Buy All -8.07%
Assets Rebalanced
None
2023-07-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 15.12% -4.44%
DVA DaVita Inc. Buy 16.22% 2.35%
KIDS OrthoPediatrics Corp. Buy 11.28% 2.05%
SMTI Sanara MedTech Inc. Buy 7.24% 0.5%
CUTR Cutera, Inc. Buy 7.17% -0.44%
INSM Insmed Incorporated Buy 12.96% -1.76%
MTD Mettler-Toledo International Inc. Buy 13.24% 0.32%
PACB Pacific Biosciences of California, Inc. Sell -6.63% -6.59%
AMN AMN Healthcare Services, Inc. Sell -6.04% -1.98%
HQY HealthEquity, Inc. Sell -5.98% -0.91%
BLUE bluebird bio, Inc. Sell -5.42% 8.46%
BCRX BioCryst Pharmaceuticals, Inc. Sell -5.93% 0%
The percentage of cash held in the portfolio is: 46.77%
New Assets Added
  • BCRX
Assets Removed
Asset Action Perf %
CBAY Sell All 5.84%
MRTX Sell All -10.94%
OPCH Buy All -6.03%
Assets Rebalanced
None
2023-07-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
CBAY CymaBay Therapeutics, Inc. Buy 16.67% 7.95%
SGMO Sangamo Therapeutics, Inc. Buy 16.47% 6.67%
DVA DaVita Inc. Buy 15.75% 1.87%
MRTX Mirati Therapeutics, Inc. Buy 14.33% -7.32%
KIDS OrthoPediatrics Corp. Buy 10.77% -0.14%
SMTI Sanara MedTech Inc. Buy 6.91% -1.66%
CUTR Cutera, Inc. Buy 7.29% 3.77%
INSM Insmed Incorporated Buy 12.87% 0%
MTD Mettler-Toledo International Inc. Buy 12.87% 0%
PACB Pacific Biosciences of California, Inc. Sell -6.53% -7.68%
OPCH Option Care Health, Inc. Sell -6.13% -2.35%
AMN AMN Healthcare Services, Inc. Sell -5.78% 0%
HQY HealthEquity, Inc. Sell -5.78% 0%
BLUE bluebird bio, Inc. Sell -5.78% 0%
The percentage of cash held in the portfolio is: 16.08%
New Assets Added
  • INSM
  • MTD
  • AMN
  • HQY
  • BLUE
Assets Removed
Asset Action Perf %
STAA Sell All 12.11%
INO Sell All 19.76%
DXCM Sell All 4.72%
BLFS Buy All 9.25%
RARE Buy All 5.32%
EBS Buy All 4.46%
Assets Rebalanced
None
2023-07-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
STAA STAAR Surgical Company Buy 10.72% 7.72%
INO Inovio Pharmaceuticals, Inc. Buy 11.28% 13.34%
DXCM DexCom, Inc. Buy 10.39% 4.48%
CBAY CymaBay Therapeutics, Inc. Buy 15.96% 0.82%
SGMO Sangamo Therapeutics, Inc. Buy 16.76% 5.93%
DVA DaVita Inc. Buy 16.3% 2.85%
MRTX Mirati Therapeutics, Inc. Buy 14.98% -5.45%
KIDS OrthoPediatrics Corp. Buy 11.06% 0.09%
SMTI Sanara MedTech Inc. Buy 7.2% 0%
CUTR Cutera, Inc. Buy 7.2% 0%
BLFS BioLife Solutions, Inc. Sell -5.96% -1.24%
RARE Ultragenyx Pharmaceutical Inc. Sell -5.54% 5.79%
EBS Emergent BioSolutions Inc. Sell -5.7% 3.15%
PACB Pacific Biosciences of California, Inc. Sell -6.66% -7.14%
OPCH Option Care Health, Inc. Sell -6.14% 0%
The percentage of cash held in the portfolio is: 8.14%
New Assets Added
  • SMTI
  • CUTR
  • OPCH
Assets Removed
Asset Action Perf %
ALDX Sell All 1.55%
RGNX Sell All -5.3%
Assets Rebalanced
None
2023-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALDX Aldeyra Therapeutics, Inc. Buy 10.19% 1.68%
RGNX REGENXBIO Inc. Buy 9.75% -2.75%
STAA STAAR Surgical Company Buy 10.15% 1.23%
INO Inovio Pharmaceuticals, Inc. Buy 11.58% 15.48%
DXCM DexCom, Inc. Buy 10.28% 2.57%
CBAY CymaBay Therapeutics, Inc. Buy 15.93% -0.09%
SGMO Sangamo Therapeutics, Inc. Buy 16.42% 2.96%
DVA DaVita Inc. Buy 16.24% 1.69%
MRTX Mirati Therapeutics, Inc. Buy 15.29% -4.25%
KIDS OrthoPediatrics Corp. Buy 11.14% 0%
BLFS BioLife Solutions, Inc. Sell -6.03% -1.64%
RARE Ultragenyx Pharmaceutical Inc. Sell -5.54% 6.47%
EBS Emergent BioSolutions Inc. Sell -5.66% 4.46%
PACB Pacific Biosciences of California, Inc. Sell -6.58% -5.12%
The percentage of cash held in the portfolio is: -3.14%
New Assets Added
  • KIDS
Assets Removed
Asset Action Perf %
CDNA Sell All 19.26%
MCRB Buy All 10.5%
Assets Rebalanced
None
2023-07-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDNA CareDx, Inc Buy 9.54% -1.15%
ALDX Aldeyra Therapeutics, Inc. Buy 10.44% 1.29%
RGNX REGENXBIO Inc. Buy 9.7% -5.93%
STAA STAAR Surgical Company Buy 10.24% -0.68%
INO Inovio Pharmaceuticals, Inc. Buy 11.69% 13.34%
DXCM DexCom, Inc. Buy 10.32% 0.1%
CBAY CymaBay Therapeutics, Inc. Buy 16.57% 1%
SGMO Sangamo Therapeutics, Inc. Buy 15.92% -2.96%
DVA DaVita Inc. Buy 16.42% 0%
MRTX Mirati Therapeutics, Inc. Buy 16.42% 0%
MCRB Seres Therapeutics, Inc. Sell -5.37% 9.16%
BLFS BioLife Solutions, Inc. Sell -5.51% 9.69%
RARE Ultragenyx Pharmaceutical Inc. Sell -6.07% 0.47%
EBS Emergent BioSolutions Inc. Sell -5.89% 3.41%
PACB Pacific Biosciences of California, Inc. Sell -6.42% 0.31%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • DVA
  • MRTX
Assets Removed
Asset Action Perf %
TDOC Sell All -2.93%
Assets Rebalanced
None
2023-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDNA CareDx, Inc Buy 9.48% -2.08%
TDOC Teladoc Health, Inc. Buy 10.47% 1.27%
ALDX Aldeyra Therapeutics, Inc. Buy 10.67% 3.23%
RGNX REGENXBIO Inc. Buy 10.13% -1.96%
STAA STAAR Surgical Company Buy 10.44% 0.98%
INO Inovio Pharmaceuticals, Inc. Buy 9.65% -6.59%
DXCM DexCom, Inc. Buy 10.26% -0.72%
CBAY CymaBay Therapeutics, Inc. Buy 17.57% 6.85%
SGMO Sangamo Therapeutics, Inc. Buy 16.44% 0%
MCRB Seres Therapeutics, Inc. Sell -5.54% 6.49%
BLFS BioLife Solutions, Inc. Sell -5.82% 4.83%
RARE Ultragenyx Pharmaceutical Inc. Sell -6.11% -0.02%
EBS Emergent BioSolutions Inc. Sell -6.07% 0.66%
PACB Pacific Biosciences of California, Inc. Sell -6.46% 0%
The percentage of cash held in the portfolio is: 24.9%
New Assets Added
  • SGMO
  • PACB
Assets Removed
None
Assets Rebalanced
None
2023-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDNA CareDx, Inc Buy 9.49% -1.96%
TDOC Teladoc Health, Inc. Buy 10.35% 0.12%
ALDX Aldeyra Therapeutics, Inc. Buy 11.22% 8.54%
RGNX REGENXBIO Inc. Buy 10.13% -1.96%
STAA STAAR Surgical Company Buy 10.48% 1.41%
INO Inovio Pharmaceuticals, Inc. Buy 9.95% -3.76%
DXCM DexCom, Inc. Buy 10.38% 0.45%
CBAY CymaBay Therapeutics, Inc. Buy 16.45% 0%
MCRB Seres Therapeutics, Inc. Sell -5.42% 8.59%
BLFS BioLife Solutions, Inc. Sell -5.98% 2.17%
RARE Ultragenyx Pharmaceutical Inc. Sell -6.05% 1.11%
EBS Emergent BioSolutions Inc. Sell -5.9% 3.54%
The percentage of cash held in the portfolio is: 34.89%
New Assets Added
  • CBAY
Assets Removed
None
Assets Rebalanced
None
2023-06-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDNA CareDx, Inc Buy 9.63% -1.27%
TDOC Teladoc Health, Inc. Buy 10.4% -0.16%
ALDX Aldeyra Therapeutics, Inc. Buy 10.65% 2.2%
RGNX REGENXBIO Inc. Buy 10.13% -2.75%
STAA STAAR Surgical Company Buy 10.42% 0%
INO Inovio Pharmaceuticals, Inc. Buy 10.42% 0%
DXCM DexCom, Inc. Buy 10.42% 0%
MCRB Seres Therapeutics, Inc. Sell -5.35% 10.5%
BLFS BioLife Solutions, Inc. Sell -6.16% 0%
RARE Ultragenyx Pharmaceutical Inc. Sell -6.16% 0%
EBS Emergent BioSolutions Inc. Sell -6.16% 0%
The percentage of cash held in the portfolio is: 51.75%
New Assets Added
  • STAA
  • INO
  • DXCM
  • BLFS
  • RARE
  • EBS
Assets Removed
None
Assets Rebalanced
None
2023-06-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDNA CareDx, Inc Buy 9.86% 1.15%
TDOC Teladoc Health, Inc. Buy 10.41% 0%
ALDX Aldeyra Therapeutics, Inc. Buy 10.41% 0%
RGNX REGENXBIO Inc. Buy 10.41% 0%
MCRB Seres Therapeutics, Inc. Sell -5.55% 7.06%
The percentage of cash held in the portfolio is: 64.46%
New Assets Added
  • TDOC
  • ALDX
  • RGNX
Assets Removed
None
Assets Rebalanced
None
2023-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDNA CareDx, Inc Buy 9.8% 0%
MCRB Seres Therapeutics, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 96.2%
New Assets Added
  • CDNA
  • MCRB
Assets Removed
None
Assets Rebalanced
None
2023-06-19 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDCO Sell All 5.44%
AMED Sell All 14.95%
Assets Rebalanced
None
2023-06-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDCO Patterson Companies, Inc. Buy 11.54% 3.29%
AMED Amedisys, Inc. Buy 10.71% 14.76%
The percentage of cash held in the portfolio is: 77.75%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All 8.22%
TDOC Sell All 5.75%
Assets Rebalanced
None
2023-06-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
TDOC Teladoc Health, Inc. Buy 11.76% 4.53%
CYH Community Health Systems, Inc. Buy 12.33% 10.08%
PDCO Patterson Companies, Inc. Buy 11.25% 0.41%
AMED Amedisys, Inc. Buy 10.76% 14.95%
The percentage of cash held in the portfolio is: 53.91%
New Assets Added
None
Assets Removed
Asset Action Perf %
PETS Sell All -10.55%
ACHC Buy All -6.08%
Assets Rebalanced
None
2023-06-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
PETS PetMed Express, Inc. Buy 12.7% -3.17%
TDOC Teladoc Health, Inc. Buy 11.27% -0.08%
CYH Community Health Systems, Inc. Buy 11.02% -1.86%
PDCO Patterson Companies, Inc. Buy 11.44% 1.92%
AMED Amedisys, Inc. Buy 10.83% 15.52%
ACHC Acadia Healthcare Company, Inc. Sell -6.15% 0.83%
The percentage of cash held in the portfolio is: 48.89%
New Assets Added
None
Assets Removed
Asset Action Perf %
ABUS Sell All -3.88%
USPH Sell All 7.9%
ICPT Sell All 15.5%
Assets Rebalanced
None
2023-06-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
USPH U.S. Physical Therapy, Inc. Buy 11.89% 7.35%
ICPT Intercept Pharmaceuticals, Inc. Buy 12.68% 19.4%
PETS PetMed Express, Inc. Buy 12.75% -1.49%
TDOC Teladoc Health, Inc. Buy 11.37% 2.14%
CYH Community Health Systems, Inc. Buy 11.02% -0.53%
ABUS Arbutus Biopharma Corporation Buy 10.91% -1.55%
PDCO Patterson Companies, Inc. Buy 11.33% 2.22%
AMED Amedisys, Inc. Buy 10.79% 16.51%
ACHC Acadia Healthcare Company, Inc. Sell -6.13% -0.12%
The percentage of cash held in the portfolio is: 13.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Sell All -8.41%
Assets Rebalanced
None
2023-06-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
USPH U.S. Physical Therapy, Inc. Buy 11.46% 5.09%
ICPT Intercept Pharmaceuticals, Inc. Buy 12.19% 16.67%
PETS PetMed Express, Inc. Buy 12.91% 1.29%
TVTX Travere Therapeutics, Inc. Buy 10.91% -1.1%
TDOC Teladoc Health, Inc. Buy 11.52% 5.16%
CYH Community Health Systems, Inc. Buy 11.11% 1.86%
ABUS Arbutus Biopharma Corporation Buy 11.08% 1.55%
PDCO Patterson Companies, Inc. Buy 11.12% 1.92%
AMED Amedisys, Inc. Buy 10.62% 16.52%
ACHC Acadia Healthcare Company, Inc. Sell -6% 0.33%
The percentage of cash held in the portfolio is: 3.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
EVH Buy All -5.05%
CYTK Buy All -1.55%
VKTX Buy All -11.44%
Assets Rebalanced
None
2023-06-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
USPH U.S. Physical Therapy, Inc. Buy 11.55% 6.26%
ICPT Intercept Pharmaceuticals, Inc. Buy 11.49% 10.23%
PETS PetMed Express, Inc. Buy 12.59% -0.97%
TVTX Travere Therapeutics, Inc. Buy 11.69% 6.26%
TDOC Teladoc Health, Inc. Buy 11.64% 6.5%
CYH Community Health Systems, Inc. Buy 11.08% 1.86%
ABUS Arbutus Biopharma Corporation Buy 10.97% 0.78%
PDCO Patterson Companies, Inc. Buy 10.94% 0.52%
AMED Amedisys, Inc. Buy 10.57% 16.23%
EVH Evolent Health, Inc. Sell -5.86% -3.14%
CYTK Cytokinetics, Incorporated Sell -5.62% 1.07%
VKTX Viking Therapeutics, Inc. Sell -6.25% -10.02%
ACHC Acadia Healthcare Company, Inc. Sell -5.94% 1.18%
The percentage of cash held in the portfolio is: 21.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 21.71%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings